,Start Date,Start Price,End Date,End Price,Weekly Returns,Bin Label,News,Basics
0,2023-01-08,265.9811706542969,2023-01-15,262.62738037109375,-0.012609126709808072,D2,"[{""date"": ""20230108203241"", ""headline"": ""15 Most Advanced Countries in Medicine"", ""summary"": ""In this article, we take a look at the 15 most advanced countries in medicine. You can skip our detailed analysis of the healthcare industry and go directly to 5 Most Advanced Countries in Medicine. The recent pandemic was the best reflection of the advancements in the field of medicine. Vaccines were developed at a [\u2026]""}, {""date"": ""20230109163600"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slid 1.85% to $270.12 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230109171005"", ""headline"": ""Why Amgen (AMGN) is Poised to Beat Earnings Estimates Again"", ""summary"": ""Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""20230109225010"", ""headline"": ""Amgen (AMGN) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $270.12, moving -1.85% from the previous trading session.""}, {""date"": ""20230110163600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.39% to $273.88 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230110233011"", ""headline"": ""10 Most Fined Pharmaceutical Companies in the World"", ""summary"": ""In this article, we will be taking a look at the 10 most fined pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to see the 5 Most Fined Pharmaceutical Companies in the World. Pharmaceutical companies have often been derided by conspiracy theorists who coined the term \u201cBig Pharma\u201d. The [\u2026]""}, {""date"": ""20230111123448"", ""headline"": ""Ranking The 10 Largest Biotechs By Pipeline"", ""summary"": ""The pipeline is the heart of all drug discovery companies, leading to all growth in the future. Here we rank biotechs by pipeline, click to see the list.""}, {""date"": ""20230111163600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 0.35% to $272.91 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230111191755"", ""headline"": ""FDRR: Designed For Inflation And Still Unconvincing"", ""summary"": ""Fidelity Dividend ETF for Rising Rates ETF invests in dividend stocks that should profit from rising rates. Here's a rundown on FDRR and whether it is right for you.""}, {""date"": ""20230112093956"", ""headline"": ""IBB: A History Of Outperformance During Recessions"", ""summary"": ""iShares Biotechnology has outperformed the S&P 500 during all 3 recessions in the U.S. since inception in early 2001. See why I'm bullish about IBB ETF now.""}, {""date"": ""20230112132900"", ""headline"": ""Will 2023 be the year that pharma M&A makes a comeback?"", ""summary"": ""A handful of acquisitions this week point to a more deal-friendly year for biopharma and biotech companies.""}, {""date"": ""20230112163600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. dropped 0.73% to $270.92 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230113120000"", ""headline"": ""FOCUS-Drug companies favor biotech meds over pills, citing new U.S. law"", ""summary"": ""Drugmakers are prioritizing complex biotech medicines over treatments that can be given as pills because recent U.S. legislation gives biologics a longer runway before becoming subject to government price limits, top industry executives said this week.  The Inflation Reduction Act (IRA), which Democrats passed last August, for the first time allows the government's Medicare health plan for people age 65 and over to negotiate the prices it is willing to pay for certain medications.  The pharmaceutical industry, whose members gathered in the thousands this week in San Francisco for the annual JP Morgan Healthcare conference, opposed the legislation and has begun implementing strategies to mitigate its impact.""}, {""date"": ""20230113130428"", ""headline"": ""Hoping For A Roaring Bull Run? Think Again!"", ""summary"": ""Relying on the high-flyers of tomorrow is a strategy that is rarely successful, emotionally taxing, and not scalable. Check out our strategy - and five picks.""}, {""date"": ""20230113184451"", ""headline"": ""2023 Market Preview: Value Should Continue To Lead"", ""summary"": ""The market's history after negative years is usually positive. What we expect to work in 2023: Industrials and consumer staples. Click for our market preview.""}, {""date"": ""20230113224510"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $271.73 in the latest trading session, marking a +0.3% move from the prior day.""}, {""date"": ""20230114060150"", ""headline"": ""Amgen: Dividend Growth Secure But Keep An Eye On Debt, Margins"", ""summary"": ""Amgen has been able to grow dividends at a rate of 11% over the past 5 years. Read more to know why AMGN stock is a hold at its current valuation.""}, {""date"": ""20230114110110"", ""headline"": ""Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 66% gain"", ""summary"": ""If you want to compound wealth in the stock market, you can do so by buying an index fund. But you can do a lot better...""}, {""date"": ""20230114150300"", ""headline"": ""A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them."", ""summary"": ""Pharmaceutical companies are grappling with the arrival in the U.S. of sweeping new legislation meant to blunt drug prices.  The impact in 2023 may actually be higher drug prices.  President Biden last year signed into law the bill dubbed the Inflation Reduction Act, empowering Medicare, the country\u2019s biggest buyer of prescription drugs, to negotiate how much it pays for certain high-price therapies.""}, {""date"": ""20230115150011"", ""headline"": ""25 Biggest California Companies and Stocks"", ""summary"": ""In this article, we will be taking a look at the 25 biggest California companies and stocks. To skip our detailed analysis, you can go directly to see the 5 Biggest California Companies and Stocks. California is not just the most populous state in the U.S. with over 39 million residents, but it is also [\u2026]""}, {""date"": ""20230115234308"", ""headline"": ""My 2023 Picks For My Portfolio"", ""summary"": ""I have started a new investment account with initial funding added around November 15, 2022. Check out my thoughts as to the stocks I will pick for investment.""}]","{""assetTurnoverTTM"": 0.4257, ""bookValue"": 3661, ""cashRatio"": 0.48632625741059476, ""currentRatio"": 1.4143, ""ebitPerShare"": 4.145, ""eps"": 3.0037, ""ev"": 171455, ""fcfMargin"": 0.3376, ""fcfPerShareTTM"": 16.4513, ""grossMargin"": 0.7446, ""inventoryTurnoverTTM"": 1.421, ""longtermDebtTotalAsset"": 0.5736, ""longtermDebtTotalCapital"": 0.8767, ""longtermDebtTotalEquity"": 10.2032, ""netDebtToTotalCapital"": 0.735, ""netDebtToTotalEquity"": 8.5539, ""netMargin"": 0.2363, ""operatingMargin"": 0.3261, ""payoutRatioTTM"": 0.6404, ""pb"": 38.2789, ""peTTM"": 21.3887, ""pfcfTTM"": 15.9521, ""pretaxMargin"": 0.2556, ""psTTM"": 5.3238, ""quickRatio"": 1.1, ""receivablesTurnoverTTM"": 5.034, ""roaTTM"": 0.106, ""roeTTM"": 2.4611, ""roicTTM"": 0.1621, ""rotcTTM"": 0.2386, ""salesPerShare"": 12.7119, ""sgaToSale"": 0.2554, ""totalDebtToEquity"": 10.6378, ""totalDebtToTotalAsset"": 0.598, ""totalDebtToTotalCapital"": 0.9141, ""totalRatio"": 1.0596, ""period"": ""2022-12-31""}"
1,2023-01-15,262.62738037109375,2023-01-22,254.4217987060547,-0.031244197209919777,D4,"[{""date"": ""20230115150011"", ""headline"": ""25 Biggest California Companies and Stocks"", ""summary"": ""In this article, we will be taking a look at the 25 biggest California companies and stocks. To skip our detailed analysis, you can go directly to see the 5 Biggest California Companies and Stocks. California is not just the most populous state in the U.S. with over 39 million residents, but it is also [\u2026]""}, {""date"": ""20230115234308"", ""headline"": ""My 2023 Picks For My Portfolio"", ""summary"": ""I have started a new investment account with initial funding added around November 15, 2022. Check out my thoughts as to the stocks I will pick for investment.""}, {""date"": ""20230116140002"", ""headline"": ""How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings"", ""summary"": ""Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.""}, {""date"": ""20230117024743"", ""headline"": ""Amgen Reinforcing Its Portfolio"", ""summary"": ""Amgen's newly acquired products bring in almost $1 billion quarterly, all from the U.S. Read what this could mean for AMGN stock in the coming years.""}, {""date"": ""20230117134201"", ""headline"": ""Amgen (NASDAQ:AMGN) Has Announced That It Will Be Increasing Its Dividend To $2.13"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) will increase its dividend from last year's comparable payment on the 8th of March to $2.13...""}, {""date"": ""20230117150620"", ""headline"": ""Dow Jones Drops After Weak Manufacturing Data; Goldman Sachs Slides On Earnings Miss"", ""summary"": ""The Dow Jones dropped Tuesday ahead of more key inflation data due out Wednesday. Goldman Sachs fell on an earnings miss.""}, {""date"": ""20230117163600"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.85% to $269.42 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230118113541"", ""headline"": ""Blue-Chip Stocks And Red Flags - Things To Consider In Your Due Diligence"", ""summary"": ""Investing in dividend-paying blue-chip companies is a proven strategy for reliable long-term returns. Read more about the pitfalls with this strategy.""}, {""date"": ""20230118145505"", ""headline"": ""Dow Jones Rises After Cool Inflation Report, Weak Retail Sales; Tesla Extends Gains"", ""summary"": ""The Dow Jones Industrial Average rose Wednesday on a cool inflation report and weak retail sales. Tesla stock raced higher, looking to add to Tuesday's surge.""}, {""date"": ""20230118163600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.87% to $264.39 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230118164605"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: December/Full Year 2022 Review"", ""summary"": ""My passive income was up by 46.50% on a year-over-year basis during December. For the full-year in 2022, my passive income rose by 23.73%. Click to read more.""}, {""date"": ""20230118202659"", ""headline"": ""Bristol Myers Squibb's New Products Need More Insurance Coverage, But Still A Buy"", ""summary"": ""Bristol Myers Squibb touted the launch of 9 new products in the U.S. While these products need more insurance coverage, read why I still rate BMY stock a Buy.""}, {""date"": ""20230119150043"", ""headline"": ""Dow Jones Falls 225 Points After Jobless Claims; Netflix Earnings Due"", ""summary"": ""The Dow Jones Industrial Average fell 225 points Thursday after first-time jobless claims. Netflix earnings are due out after the market close.""}, {""date"": ""20230119163600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.89% to $262.03 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230119225010"", ""headline"": ""Amgen (AMGN) Dips More Than Broader Markets: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $262.03 in the latest trading session, marking a -0.89% move from the prior day.""}, {""date"": ""20230120075435"", ""headline"": ""Amgen (AMGN) Presents At 41st Annual Healthcare Conference - Slideshow"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20230120224510"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $263.24, marking a +0.46% move from the previous day.""}, {""date"": ""20230121130014"", ""headline"": ""Insiders who sold Amgen Inc.'s (NASDAQ:AMGN) earlier this year didn't have to weather this week's 3.1% slide"", ""summary"": ""Amgen Inc.'s (NASDAQ:AMGN) value has fallen 3.1% in the last week, but insiders who sold US$5.2m worth of stock over...""}, {""date"": ""20230121140000"", ""headline"": ""3 Dividend Stocks You Can Safely Hold for Years"", ""summary"": ""Most companies currently paying dividends are equipped to do so for the foreseeable future.  Only a handful of dividend-paying companies, however, are built to continue dishing out dividends into the distant unknown as unforeseen changes arise.  Here's a closer look at three dividend stocks you can safely hold for years.""}]","{""assetTurnoverTTM"": 0.4257, ""bookValue"": 3661, ""cashRatio"": 0.48632625741059476, ""currentRatio"": 1.4143, ""ebitPerShare"": 4.145, ""eps"": 3.0037, ""ev"": 171455, ""fcfMargin"": 0.3376, ""fcfPerShareTTM"": 16.4513, ""grossMargin"": 0.7446, ""inventoryTurnoverTTM"": 1.421, ""longtermDebtTotalAsset"": 0.5736, ""longtermDebtTotalCapital"": 0.8767, ""longtermDebtTotalEquity"": 10.2032, ""netDebtToTotalCapital"": 0.735, ""netDebtToTotalEquity"": 8.5539, ""netMargin"": 0.2363, ""operatingMargin"": 0.3261, ""payoutRatioTTM"": 0.6404, ""pb"": 38.2789, ""peTTM"": 21.3887, ""pfcfTTM"": 15.9521, ""pretaxMargin"": 0.2556, ""psTTM"": 5.3238, ""quickRatio"": 1.1, ""receivablesTurnoverTTM"": 5.034, ""roaTTM"": 0.106, ""roeTTM"": 2.4611, ""roicTTM"": 0.1621, ""rotcTTM"": 0.2386, ""salesPerShare"": 12.7119, ""sgaToSale"": 0.2554, ""totalDebtToEquity"": 10.6378, ""totalDebtToTotalAsset"": 0.598, ""totalDebtToTotalCapital"": 0.9141, ""totalRatio"": 1.0596, ""period"": ""2022-12-31""}"
2,2023-01-22,254.4217987060547,2023-01-29,245.15304565429688,-0.0364306560951031,D4,"[{""date"": ""20230123000500"", ""headline"": ""2 Top Passive-Income Stocks to Own in 2023"", ""summary"": ""Passive-income stocks are a proven way to cushion your portfolio against market volatility.  What's more, top shelf dividend plays also tend to outperform other asset classes in bull markets.  Not all dividend stocks are cut from the same cloth, however.""}, {""date"": ""20230123100202"", ""headline"": ""Healthcare Outlook 2023"", ""summary"": ""Healthcare significantly outperformed the broader market last year, after two years of underperforming the S&P 500. Read more here.""}, {""date"": ""20230123134103"", ""headline"": ""Pluri Inc (Pluristem Therapeutics) Holds No Hope For The Weak"", ""summary"": ""Pluri Inc is a biotechnology research company developing medical, pharma, and food products from placenta-based stem cells R&D. Read our outlook on PLUR stock.""}, {""date"": ""20230124205348"", ""headline"": ""Dogs of the Dow 2023: 5 Dividend Stocks for Income Investors"", ""summary"": ""The start of the year is a good time to add to your existing portfolio or start new positions. An excellent source to look for ideas is among the Dogs of the Dow. These stocks are the highest-yielding ones in the Dow Jones Industrial Average (DJIA) at the end of the preceding year. The strategy assumes the stocks are temporarily mispriced, and thus the yields are high. Additionally, the Dogs of the Dow are blue-chip stocks with sustainable growth and excellent reputations. Hence, they make good""}, {""date"": ""20230125131451"", ""headline"": ""Why Viridian Therapeutics Is One Of My 2023 Top Picks"", ""summary"": ""Viridian was one of my top picks in 2022 and it made the 2023 list again. Click here to see our take on VRDN stock.""}, {""date"": ""20230125135901"", ""headline"": ""Amgen (AMGN) to Report Q4 Earnings: What's in the Cards?"", ""summary"": ""Volume growth from Amgen's (AMGN) key drugs like Prolia, Otezla, Repatha and others is expected to have been partially offset by biosimilar/generic competition for mature drugs.""}, {""date"": ""20230125150003"", ""headline"": ""Earnings Preview: GSK (GSK) Q4 Earnings Expected to Decline"", ""summary"": ""Glaxo (GSK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20230126132300"", ""headline"": ""2 Top Biotech Stocks to Buy for the Long Haul"", ""summary"": ""Equity markets are entirely unpredictable in the short run.  The biotech industry is a great place to look for stocks that can survive down markets and be successful over long periods since the drugs these companies develop are so critical to their customers' lives.  Let's look at two biotech stocks to buy today and hold on to for a while: Amgen (NASDAQ: AMGN) and Moderna (NASDAQ: MRNA).""}, {""date"": ""20230126140011"", ""headline"": ""Is Amgen Inc. (NASDAQ:AMGN) Trading At A 29% Discount?"", ""summary"": ""In this article we are going to estimate the intrinsic value of Amgen Inc. ( NASDAQ:AMGN ) by estimating the company's...""}, {""date"": ""20230126170738"", ""headline"": ""Warren tells FTC she is \""particularly concerned\"" about Amgen and Indivior deals"", ""summary"": ""Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals.  In a letter dated Wednesday, Warren said that she was focused on Amgen's plan to buy Horizon Therapeutics , and addiction specialist Indivior's plan to buy Opiant for $145 million, which was announced in mid-November.  \""Given these companies' records of anti-competitive business practices, these acquisitions could cause further price increases on lifesaving drugs and prevent affordable alternatives from entering the market,\"" she wrote in the letter to FTC Chair Lina Khan as well as Commissioners Rebecca Slaughter and Alvaro Bedoya, all of whom are Democrats.""}, {""date"": ""20230126204351"", ""headline"": ""UPDATE 2-U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals"", ""summary"": ""Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals.  In a letter dated Wednesday, Warren said that she was focused on Amgen's plan to buy Horizon Therapeutics , and addiction specialist Indivior's plan to buy Opiant for $145 million, which was announced in mid-November.  \""Given these companies' records of anti-competitive business practices, these acquisitions could cause further price increases on lifesaving drugs and prevent affordable alternatives from entering the market,\"" she wrote in the letter to FTC Chair Lina Khan as well as Commissioners Rebecca Slaughter and Alvaro Bedoya, all of whom are Democrats.""}, {""date"": ""20230126210000"", ""headline"": ""AMGEN ANNOUNCES WEBCAST OF 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will report its fourth quarter and full year 2022 financial results on Tuesday, Jan. 31, 2023, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 4:30 p.m. ET. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.""}, {""date"": ""20230126224317"", ""headline"": ""U.S. Senator Warren 'particularly concerned' about Amgen, Indivior deals"", ""summary"": ""Sen. Elizabeth Warren, an outspoken critic of corporate consolidation, wrote to the U.S. Federal Trade Commission to express concern about two pending pharmaceutical deals.""}, {""date"": ""20230126224510"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $254.88, moving -0.65% from the previous trading session.""}, {""date"": ""20230127073400"", ""headline"": ""Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl >BMY"", ""summary"": ""By Colin Kellaher Bristol Myers Squibb Co. on Friday said the European Medicines Agency's Committee for Medicinal Products for Human Use has recommended...""}]",{}
3,2023-01-29,245.15304565429688,2023-02-05,236.9571075439453,-0.033431924488138254,D4,"[{""date"": ""20230130125258"", ""headline"": ""Amgen lays off 300 employees "", ""summary"": ""Amgen Inc said on Monday that it had let go about 300 employees based in the United States, mainly in its commercial team, citing recent organizational changes to better manage the company against \""industry headwinds\"". (Reporting by Bhanvi Satija in Bengaluru; Editing by...""}, {""date"": ""20230130133000"", ""headline"": ""SCHG Adds Growth In A 2-ETF Package That Beat The S&P 500 Over 10 Years"", ""summary"": ""For this article, I decided to take a look at SCHG, an ETF I hadn't previously reviewed. Click here to read what happened after combining this ETF with SCHD.""}, {""date"": ""20230131130700"", ""headline"": ""First Humira Biosimilar Price Highlights Cost-Saving Challenges"", ""summary"": ""Hopes that competition would bring immediate cost savings was tamped down when Amgen announced a pricing scheme for its generic-style competitor to AbbVie's...""}, {""date"": ""20230131152542"", ""headline"": ""Amgen launches biosimilar version of AbbVie's Humira"", ""summary"": ""Amgen Inc said on Tuesday it launched a biosimilar version of AbbVie Inc's big selling arthritis treatment, the first such competition for Humira in the United States.""}, {""date"": ""20230131162100"", ""headline"": ""Amgen 4Q Profit Declines, Revenue Ticks Down Slightly"", ""summary"": ""By Denny Jacob Amgen Inc. on Tuesday reported lower profit and revenue that dipped in the latest quarter. The biotechnology company reported net income of...""}, {""date"": ""20230131164300"", ""headline"": ""Amgen's Q4 tops views, but 2023 guidance falls on lower end of expectations"", ""summary"": ""Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker's shares fell after hours as its 2023 guidance fell on the lower end of...""}, {""date"": ""20230131171328"", ""headline"": ""Barron's And Bloomberg 2023 Ideal Dividend Stocks Of The Year"", ""summary"": ""Two Barron\u00e2\u0080\u0099s Annual Roundtable, plus one Bloomberg Intelligence, articles published late-January listed 99 intriguing stocks for 2023. Read our analysis.""}, {""date"": ""20230131213855"", ""headline"": ""UPDATE 1-Amgen revenue falls slightly as Lilly COVID deal contributes less"", ""summary"": ""Amgen Inc on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.  Amgen reported revenue of $6.84 billion for the quarter, down from $6.85 billion a year ago, but ahead of analysts' estimates of $6.77 billion, according to Refinitiv data.  Amgen partnered with Lilly in 2020 to increase the supply of its COVID-19 antibody treatments.""}, {""date"": ""20230131213858"", ""headline"": ""Amgen revenue falls slightly as Lilly COVID deal contributes less"", ""summary"": ""Amgen Inc on Tuesday said its fourth-quarter revenue fell slightly as a 4% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.""}, {""date"": ""20230131214400"", ""headline"": ""Amgen\u2019s Q4 tops views, but 2023 guidance falls on lower end of expectations"", ""summary"": ""Amgen Inc. topped Wall Street expectations for its fourth quarter, but the drug maker's shares fell after hours as its 2023 guidance fell on the lower end of Wall Street's expectations.""}, {""date"": ""20230131215923"", ""headline"": ""Stocks moving in after hours: AMD, Snap, Match Group, Electronic Arts, Amgen"", ""summary"": ""Yahoo Finance Live co-host Seana Smith discusses stocks moving in after-hours trading.""}, {""date"": ""20230131222510"", ""headline"": ""Amgen (AMGN) Surpasses Q4 Earnings and Revenue Estimates"", ""summary"": ""Amgen (AMGN) delivered earnings and revenue surprises of 1.24% and 1.49%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20230131233905"", ""headline"": ""Amgen Inc. (AMGN) Q4 2022 Earnings Call Transcript"", ""summary"": ""Call Start: 16:30 January 1, 0000 6:00 PM ETAmgen Inc.""}, {""date"": ""20230201054900"", ""headline"": ""Nasdaq jumps 2% to end at highest since September after Fed raises rate by a quarter-point, Powell signals few more hikes to go"", ""summary"": ""U.S. stocks finish higher on Wednesday, reversing earlier losses after the Federal Reserve raised its policy interest rate by 25 basis points, as widely...""}, {""date"": ""20230201092409"", ""headline"": ""Compared to Estimates, Amgen (AMGN) Q4 Earnings: A Look at Key Metrics"", ""summary"": ""While the top- and bottom-line numbers for Amgen (AMGN) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.""}, {""date"": ""20230201100000"", ""headline"": ""Amgen, Travelers share losses lead Dow's 185-point fall"", ""summary"": ""The Dow Jones Industrial Average is down Wednesday morning with shares of Amgen and Travelers delivering the stiffest headwinds for the blue-chip average....""}, {""date"": ""20230201110100"", ""headline"": ""Amgen, Travelers share losses lead Dow's 336-point fall"", ""summary"": ""Dragged down by losses for shares of Amgen and Travelers, the Dow Jones Industrial Average is trading down Wednesday morning. The Dow was most recently...""}, {""date"": ""20230201124241"", ""headline"": ""Amgen Records Slight Fall In Quarterly Earnings; Lower COVID-19 Manufacturing Pacts Impact Bottomline"", ""summary"": ""Amgen Inc's (NASDAQ: AMGN) fourth-quarter revenues were $6.84 billion, beating the consensus of $6.76 billion, largely unchanged from Q4 2021, and benefited from a 4% increase in product sales, offset by lower COVID-19 manufacturing collaboration revenues. Product sales growth was driven by 10% volume growth, partially offset by a 3% lower net selling price and a 2% negative impact from foreign exchange. Excluding the 2% negative impact of foreign exchange on product sales, total revenues increa""}, {""date"": ""20230201125835"", ""headline"": ""US STOCKS-Futures dip on jitters ahead of ADP report, Fed decision"", ""summary"": ""U.S. stock index futures slipped on Wednesday as investors cautiously waited for the Federal Reserve's decision on interest rates later in the day and a reading on private job additions last month.  The Fed is widely seen as raising its target interest rate by a quarter of a percentage point in its first policy meeting of the year, after the rapid increases in 2022 to tame decades-high inflation.  Investors will also likely parse Chair Jerome Powell news conference for clues on the trajectory of future rate hikes.""}, {""date"": ""20230201130000"", ""headline"": ""Amgen Shares Slip 4.1% Following Decline in 4Q Profit, Revenue"", ""summary"": ""By Denny Jacob Amgen Inc. shares slipped 4.1% to $242.17 following lower profit and a dip in revenue in its latest quarter. The biotechnology company on...""}, {""date"": ""20230201133109"", ""headline"": ""Amgen (NASDAQ:AMGN) Is Increasing Its Dividend To $2.13"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) will increase its dividend from last year's comparable payment on the 8th of March to $2.13...""}, {""date"": ""20230201140401"", ""headline"": ""US STOCKS-Wall St set to open lower ahead of Fed decision; AMD rises on outlook"", ""summary"": ""U.S. stock indexes were set to open lower on Wednesday as investors cautiously awaited the Federal Reserve's decision on interest rates later in the day, while chipmaker Advanced Micro Devices climbed on an upbeat outlook.  The Fed is widely seen as raising its target interest rate by a quarter of a percentage point in its first policy meeting of the year, after the rapid increases in 2022 to tame decades-high inflation.  \""Consensus is that the Fed is going to talk very hawkish today even though it's only doing 25 basis points,\"" said Thomas Hayes, chairman at investment firm Great Hill Capital.""}, {""date"": ""20230201140900"", ""headline"": ""Dow's 235-point drop led by losses in Amgen, Travelers shares"", ""summary"": ""Shares of Amgen and Travelers are trading lower Wednesday afternoon, sending the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20230201153103"", ""headline"": ""Amgen (AMGN) Beats on Q4 Earnings, 2023 Sales View Disappoints"", ""summary"": ""Amgen (AMGN) beats Q4 estimates for earnings and sales. It launches Amjevita in the United States, which is the first biosimilar of Humira to be launched in the country.""}, {""date"": ""20230201155718"", ""headline"": ""US STOCKS-Wall St dips as Fed decision looms; AMD boosts chipmakers"", ""summary"": ""U.S. stock indexes fell on Wednesday ahead of the Federal Reserve's decision on interest rates later in the day, while an upbeat outlook from Advanced Micro Devices lifted chipmakers.  The Fed is widely seen as raising its target interest rate by a quarter of a percentage point in its first policy meeting of the year, after the rapid increases in 2022 to tame decades-high inflation.""}, {""date"": ""20230201163600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 2.37% to $246.41 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230201170323"", ""headline"": ""My 26 Stock ~$384k Portfolio Sports Double-Digit Returns To Start The New Year"", ""summary"": ""My portfolio, built specifically for my retirement, features growth, dividend, and risk stocks for a happy retirement. Click here to see my strategy.""}, {""date"": ""20230201181334"", ""headline"": ""US STOCKS-Wall St falls as Fed decision looms; AMD boosts chipmakers"", ""summary"": ""U.S. stock indexes fell on Wednesday ahead of the Federal Reserve's decision on interest rates later in the day, while an upbeat outlook from Advanced Micro Devices lifted chipmakers.  The Fed is widely seen as raising its target interest rate by a quarter of a percentage point in its first policy meeting of the year, after rapid increases in 2022 to tame decades-high inflation.""}, {""date"": ""20230201183218"", ""headline"": ""FOCUS-AbbVie's Humira gets a U.S. rival, but costs could stay high"", ""summary"": ""U.S. patients will finally get access to cheaper versions of AbbVie Inc\u2019s blockbuster arthritis drug Humira this year, but the cost savings are expected to be limited.  Rival drugmaker Amgen Inc on Tuesday launched Amjevita, the first biosimilar version of AbbVie\u2019s 20-year-old drug, with two tiers of pricing.  One sets a 5% discount to Humira\u2019s monthly price of $6,922.""}, {""date"": ""20230201210311"", ""headline"": ""There's A Key Element Missing From Amgen's 2023 Outlook, Making Comparisons 'Messy'"", ""summary"": ""Amgen issued an outlook that discounts its looming acquisition of Horizon Therapeutics. In response, Amgen stock skidded Wednesday morning.""}, {""date"": ""20230201220619"", ""headline"": ""Why Amgen Stock Wilted on Wednesday"", ""summary"": ""The stock of veteran biotech Amgen (NASDAQ: AMGN) was looking a little tired on Wednesday.  The company's shares fell more than 2% in price, \""thanks\"" to fourth-quarter results that didn't put smiles on investors' faces.  In contrast to gloomy Amgen, the S&P 500 index ticked up by slightly more than 1%.""}, {""date"": ""20230202050400"", ""headline"": ""S&P 500 surges to end at over five-month high, Nasdaq closes up 3.3% as Meta leads rally in tech sector stocks"", ""summary"": ""U.S. stocks ended mostly higher on Thursday after the Nasdaq Composite and the S&P 500 index surged to their highest levels in about five months, buoyed by...""}, {""date"": ""20230202140000"", ""headline"": ""TEZSPIRE\u00ae APPROVED FOR SELF-ADMINISTRATION IN THE U.S. WITH A NEW PRE-FILLED PEN"", ""summary"": ""Amgen (NASDAQ:AMGN) and AstraZeneca today announced the U.S. Food and Drug Administration (FDA) has approved TEZSPIRE\u00ae (tezepelumab-ekko) for self-administration in a pre-filled, single-use pen for patients aged 12 years and older with severe asthma.1 First approved by the FDA in December 2021, TEZSPIRE is the only biologic approved for severe asthma with no phenotype (e.g., eosinophilic or allergic) or biomarker limitation within its approved label.2-9""}, {""date"": ""20230202163600"", ""headline"": ""Amgen Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.05% higher to $246.53 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230202193534"", ""headline"": ""The 7 Most Undervalued Dow Stocks to Buy in February 2023"", ""summary"": ""While investing in the new normal seemingly focused on meme trades and other high-risk ventures, targeting the companies of the Dow Jones is always relevant, particularly if they\u2019re among the most undervalued Dow stocks to buy. Granted, this venerable list doesn\u2019t bring much excitement. However, these stalwarts command well-established businesses, meaning they likely won\u2019t steer you wrong. Before we begin, though, we need to establish some ground rules. First, none of the most undervalued Dow st""}, {""date"": ""20230202224700"", ""headline"": ""What\u2019s Ailing the Dow This Year? UnitedHealth, Chevron, J&J, Amgen."", ""summary"": ""The Dow industrials fell 39 points, or 0.1%, to 34,054, while the  gained 1.5% to 4,179 and the  was up 3.3%.  Several influential stocks in the index are in the red this year, led by  UnitedHealth  Group (ticker: UNH), which is the worst percentage loser, with an 11.1% drop to $470.83.  Other losers in the Dow include  Amgen  (AMGN),  Merck  (MRK),  Johnson & Johnson  (JNJ),  Procter & Gamble  (PG), and  Chevron  (CVX)\u2014which all are down about 6%, Bloomberg data show.""}, {""date"": ""20230203163600"", ""headline"": ""Amgen Inc. stock falls Friday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.55% to $245.17 Friday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230205072900"", ""headline"": ""Top 3 Corporate Events To Look For In 2023 (That Aren't Earnings Dates)"", ""summary"": ""We\u00e2\u0080\u0099re in the midst of the fourth quarter earnings season and already we\u00e2\u0080\u0099re seeing a cautionary setup for 2023 as corporations find ways to cut back.""}, {""date"": ""20230205170000"", ""headline"": ""AbbVie: The Dreaded Humira Cliff Is Here: Time To Sell?"", ""summary"": ""The day has arrived: Biosimilars for AbbVie's blockbuster drug Humira are now being sold in the US. See whether it's not time to sell ABBV?""}]",{}
4,2023-02-05,236.9571075439453,2023-02-12,234.37655639648438,-0.010890372414688376,D2,"[{""date"": ""20230205072900"", ""headline"": ""Top 3 Corporate Events To Look For In 2023 (That Aren't Earnings Dates)"", ""summary"": ""We\u00e2\u0080\u0099re in the midst of the fourth quarter earnings season and already we\u00e2\u0080\u0099re seeing a cautionary setup for 2023 as corporations find ways to cut back.""}, {""date"": ""20230205170000"", ""headline"": ""AbbVie: The Dreaded Humira Cliff Is Here: Time To Sell?"", ""summary"": ""The day has arrived: Biosimilars for AbbVie's blockbuster drug Humira are now being sold in the US. See whether it's not time to sell ABBV?""}, {""date"": ""20230206120017"", ""headline"": ""Is Amgen (NASDAQ:AMGN) Using Too Much Debt?"", ""summary"": ""Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...""}, {""date"": ""20230206163600"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. shed 0.54% to $243.85 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230207163600"", ""headline"": ""Amgen Inc. stock rises Tuesday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.06% higher to $244.00 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230208105000"", ""headline"": ""Beat the Dow Jones With This Unstoppable Dividend Stock"", ""summary"": ""The Dow Jones Industrial Average contains 30 of the highest quality businesses in the world.  A $10,000 investment in the stock made 10 years ago would now be worth $37,000 with dividends reinvested.  For context, that is nearly double the $20,000 that the same investment made in the Dow Jones would be worth after 10 years with dividends reinvested.""}, {""date"": ""20230208132559"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:AMGN) Q4 2022 Earnings Call Transcript January 31, 2023 Amgen Inc. misses on earnings expectations. Reported EPS is $4.09 EPS, expectations were $4.1. Operator: My name is Jason and I will be the conference facilitator today for Amgen\u2019s Fourth Quarter Full Year 2022 Financial Results Conference Call. I would now like to introduce [\u2026]""}, {""date"": ""20230208145109"", ""headline"": ""Mirati Therapeutics: Suddenly A Battleground Stock"", ""summary"": ""Mirati Therapeutics is focused on developing product candidates to address the genetic and immunological promoters of cancer. Read my analysis of MRTX stock.""}, {""date"": ""20230209075700"", ""headline"": ""AbbVie`s stock gains on Q4 results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230209080400"", ""headline"": ""AbbVie\u2019s stock gains on Q4 results"", ""summary"": ""Shares of AbbVie Inc. gained 2.4% in premarket trading on Thursday after the company beat earnings expectations for the fourth quarter of 2022. AbbVie had a...""}, {""date"": ""20230209101326"", ""headline"": ""There's A Lot To Like About Amgen's (NASDAQ:AMGN) Upcoming US$2.13 Dividend"", ""summary"": ""It looks like Amgen Inc. ( NASDAQ:AMGN ) is about to go ex-dividend in the next four days. The ex-dividend date is one...""}, {""date"": ""20230209114400"", ""headline"": ""AbbVie gains after revising estimates for Humira sales erosion"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230209143718"", ""headline"": ""How To Profit From Amgen Stock's Plunge Using Options"", ""summary"": ""Amgen (AMGN) stock has had a difficult few weeks, with the stock dropping from 295 to 240. It is currently the most oversold stock in the Dow Jones Industrial Average. When a quality company has a big drop like this, I like to use a strategy called a diagonal put spread. This option strategy is an advanced strategy because it...""}, {""date"": ""20230209163704"", ""headline"": ""AbbVie (ABBV) Beats Q4 Earnings Estimates, Misses on Sales"", ""summary"": ""AbbVie's Q4 earnings (ABBV) beat estimates, while sales miss the same. Full-year 2023 EPS falls short of estimates.""}, {""date"": ""20230209184655"", ""headline"": ""9 Upcoming Dividend Increases"", ""summary"": ""I've tracked 35 dividend increases in 2023 for your consideration. There are nine increases for next week, up from two last week. Click here to read more.""}, {""date"": ""20230209210000"", ""headline"": ""AMGEN TO PRESENT AT THE 2023 SVB SECURITIES GLOBAL BIOPHARMA CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 SVB Securities Global Biopharma Conference at 10:40 a.m. ET on Tuesday, February 14, 2023. Susan Sweeney, senior vice president, Global Marketing, Access and Capabilities at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230210033700"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230210050915"", ""headline"": ""High Yield Stock Watchlist - February 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Click here for a detailed analysis.""}, {""date"": ""20230210061800"", ""headline"": ""Medicare mulls rebates in 2025 for drug prices rising faster than inflation"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230210091200"", ""headline"": ""Chevron, Amgen share gains contribute to Dow`s 66-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230210092912"", ""headline"": ""BME: Well-Positioned Healthcare CEF For Monthly Income"", ""summary"": ""BlackRock Health Sciences Trust is a top healthcare CEF with long tenure that offers monthly distributions and an average yield. See why I'm bullish on BME CEF.""}, {""date"": ""20230211090000"", ""headline"": ""How This Income Method Could Lead To Financial Freedom"", ""summary"": ""We will go over our thesis as to how a diversified income method with low volatility could make you financially independent. Click here for our strategy.""}, {""date"": ""20230212032216"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of February 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of February 12.""}, {""date"": ""20230212203456"", ""headline"": ""12 Most Undervalued Dow Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will take a look at the 12 most undervalued dow stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Dow Stocks To Buy According To Hedge Funds. The stock market bloodbath that started in 2022 has forced investors to shun the so-called [\u2026]""}]",{}
5,2023-02-12,234.37655639648438,2023-02-19,234.52267456054688,0.0006234333600128039,U1,"[{""date"": ""20230212032216"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of February 12"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Click here to read the update for the week of February 12.""}, {""date"": ""20230212203456"", ""headline"": ""12 Most Undervalued Dow Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will take a look at the 12 most undervalued dow stocks to buy according to hedge funds. To see more such companies, go directly to 5 Most Undervalued Dow Stocks To Buy According To Hedge Funds. The stock market bloodbath that started in 2022 has forced investors to shun the so-called [\u2026]""}, {""date"": ""20230213012100"", ""headline"": ""OmniAb initiated with a buy at H.C. Wainwright on antibody collaborations, partnerships"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213015300"", ""headline"": ""ARK Invest: The 7 Words That Explain Why Wall Street Can`t Stand Cathie Wood"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213062600"", ""headline"": ""Truist Financial Sticks to Their Hold Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213072200"", ""headline"": ""Amgen price target lowered to $260 from $280 at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213082800"", ""headline"": ""Don`t Buy Viatris And Organon Just Because Of The Dividends"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230213092736"", ""headline"": ""Don't Buy Viatris And Organon Just Because Of The Dividends"", ""summary"": ""Viatris and Organon are what can currently be described as deep value plays in the pharmaceutical sector. Click for more on OGN and VTRS.""}, {""date"": ""20230213120021"", ""headline"": ""Amgen's (NASDAQ:AMGN) investors will be pleased with their notable 52% return over the last five years"", ""summary"": ""While Amgen Inc. ( NASDAQ:AMGN ) shareholders are probably generally happy, the stock hasn't had particularly good run...""}, {""date"": ""20230213163600"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.48% higher to $243.66 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230214024400"", ""headline"": ""Tuesday Talk: My Sweet CPI"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214085400"", ""headline"": ""Amgen Inc. (AMGN) SVB Securities Global Biopharma Conference (Transcript)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214100100"", ""headline"": ""Top 5 4th Quarter Trades of Compagnie Lombard Odier SCmA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230214161004"", ""headline"": ""Top Research Reports for Chevron, Novo Nordisk & Amgen"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Chevron Corporation (CVX), Novo Nordisk A/S (NVO) and Amgen Inc. (AMGN).""}, {""date"": ""20230214171853"", ""headline"": ""Health Rounds: Pancreas cancer rising faster among younger U.S. women"", ""summary"": ""Pancreas cancer rates are climbing in the U.S., but they\u2019re rising faster in younger women than in their male counterparts, a large study shows.  In other news, a drug that delivers a cancer-killing virus directly into tumors may be an effective new alternative for patients with a hard-to-treat form of breast cancer.  Pancreas cancer rates in the United States are increasing faster in younger women than in their male counterparts, a large study has found.""}, {""date"": ""20230214193800"", ""headline"": ""Amgen plans mega bond deal to help fund $28 billion Horizon Therapeutics acquisition"", ""summary"": ""Amgen Inc. plans to finance its acquisition of Horizon Therapeutics in the corporate bond market, underscoring how the Federal Reserve's inflation fight isn't drying up mega deals on Wall Street.""}, {""date"": ""20230215011200"", ""headline"": ""Amgen bond offering to help fund Horizon Therapeutics acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215020100"", ""headline"": ""FEDERATED HERMES, INC. Buys 1, Sells 4 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215020100"", ""headline"": ""Palouse Capital Management, Inc. Buys 2, Sells 3 in 4th Quarter"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215043422"", ""headline"": ""Top Merger Stocks Held By Fund Managers, Mid-Q1 2023"", ""summary"": ""Form 13F filings show fund managers' top arbitrage stocks. Find out top M&A stocks of the 28 funds I follow and this quarter's top stock.""}, {""date"": ""20230215104300"", ""headline"": ""Why Billionaires Paul Tudor Jones and George Soros Bought Up Horizon (HZNP) Stock"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215110100"", ""headline"": ""Amgen sees about $56 billion in demand for mega bond deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215121700"", ""headline"": ""Medicare mulls limiting per month costs for generic drugs at $2"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230215132901"", ""headline"": ""The Zacks Analyst Blog Highlights Chevron, Novo Nordisk, Amgen, Starbucks and General Dynamics"", ""summary"": ""Chevron, Novo Nordisk, Amgen, Starbucks and General Dynamics are part of the Zacks top Analyst Blog.""}, {""date"": ""20230215160842"", ""headline"": ""5 Stocks In The Dividend Growth Sweet Spot"", ""summary"": ""Finding companies with a high initial yield and rapid dividend growth is difficult. Here's my criteria for finding such companies.""}, {""date"": ""20230215163600"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. shed 0.40% to $240.07 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230215192100"", ""headline"": ""Amgen to raise $24 billion after seeing about $90 billion in demand for mega bond deal"", ""summary"": ""Amgen looks to raise $24 billion on Wednesday, ranking in the top 10 in terms of largest U.S. corporate bond deals ever, according to Informa Global Markets.""}, {""date"": ""20230216010845"", ""headline"": ""Competition Coming For AbbVie's Blockbuster Humira"", ""summary"": ""It\u00e2\u0080\u0099s among the prohibitively expensive biologic pharmaceuticals being replaced by cheaper \u00e2\u0080\u009cbiosimilar\u00e2\u0080\u009d copycats. Read how price relief is on the way for Humira.""}, {""date"": ""20230216050200"", ""headline"": ""AMGN Near Buy Point With Strong Fundamentals And Rising Dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216092000"", ""headline"": ""O`Keefe Stevens Advisory Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216095116"", ""headline"": ""Renaissance Technologies Top Trades This Quarter Included Apple, Amazon, Taiwan Semiconductor And More Released Here"", ""summary"": """"}, {""date"": ""20230216100200"", ""headline"": ""Dow, Amgen share losses lead Dow`s 225-point fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216102900"", ""headline"": ""Amgen Enters Oversold Territory"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216110100"", ""headline"": ""Dow, Amgen share losses lead Dow's 225-point fall"", ""summary"": ""Behind declines for shares of Dow and Amgen, the Dow Jones Industrial Average is trading down Thursday morning. Shares of Dow and Amgen have contributed to...""}, {""date"": ""20230216113600"", ""headline"": ""Dow`s 139-point drop led by losses for Microsoft, Amgen stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216120900"", ""headline"": ""Competition Coming For AbbVie`s Blockbuster Humira"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230216123500"", ""headline"": ""Dow's 139-point drop led by losses for Microsoft, Amgen stocks"", ""summary"": ""Shares of Microsoft and Amgen are trading lower Thursday afternoon, dragging the Dow Jones Industrial Average into negative territory. The Dow was most...""}, {""date"": ""20230216124500"", ""headline"": ""2 Market-Beating Dividend Stocks to Buy With $500"", ""summary"": ""Dividend-paying corporations can be particularly great picks since the steady and reliable payouts they offer help boost total returns over the long run.  Let's consider two such stocks that you can buy for less than the relatively modest sum of $500: Amgen (NASDAQ: AMGN) and Merck (NYSE: MRK).  Amgen is a biotech leader with a plentiful and diverse lineup of medicines across multiple therapeutic areas.""}, {""date"": ""20230216163600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 2.43% to $234.22 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230216180510"", ""headline"": ""Dow closes more than 100 points higher on Friday, but notches third straight week of losses on rate fears: Live updates"", ""summary"": ""A week of inflation and retail sales data has put the consumer in sharp focus. Recent comments from Fed officials have also spooked investors.""}, {""date"": ""20230216221500"", ""headline"": ""O'Keefe Stevens Advisory Q4 2022 Update"", ""summary"": ""O'Keefe Stevens Advisory recently published its Q4 2022 update. Click here to read the full fund letter.""}, {""date"": ""20230217012600"", ""headline"": ""Dow`s 60-point jump led by gains for Amgen, Merck stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230217020200"", ""headline"": ""Catalyst watch: Spotlight on retail earnings, Lucid Group, Silvergate Capital and Radware"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230217031100"", ""headline"": ""S&P 500, Dow, Nasdaq finish mixed as Fed debate continues"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230217042200"", ""headline"": ""Amgen After FY22 Earnings: Ambition Is Commendable But Debt Is Problematic"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230217064500"", ""headline"": ""\u2018Biosimilars\u2019 Were Supposed to Tame Costs for Drugs Like Humira. It Isn\u2019t Working."", ""summary"": ""AbbVie's arthritis treatment Humira and other complex drugs account for almost half of annual U.S. drug spending\u2014but just 2% of prescriptions.""}, {""date"": ""20230217085500"", ""headline"": ""Early notable gainers among liquid option names on February 17th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230217142500"", ""headline"": ""Dow's 60-point jump led by gains for Amgen, Merck stocks"", ""summary"": ""Shares of Amgen and Merck are trading higher Friday afternoon, sending the Dow Jones Industrial Average into positive territory. Shares of Amgen and Merck...""}, {""date"": ""20230217163600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 2.69% to $240.53 Friday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230217190706"", ""headline"": ""Best Stocks To Buy Now? 2 Dow Jones Stocks To Watch In 2023"", ""summary"": ""Are these the best Dow Jones Industrial Average stocks to buy in 2023?""}, {""date"": ""20230217203700"", ""headline"": ""Endowments Soared in 2021. The Next Year Was Dramatically Different."", ""summary"": ""University endowments lost 8% in fiscal 20221, slightly better than the S&P 500 but the worst decline since 2009. It was a year of two markets: The first...""}, {""date"": ""20230219110400"", ""headline"": ""The next big wave of patent cliffs is ahead; expect biopharma M&A to rise \ufffd\ufffd\ufffd report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230219210056"", ""headline"": ""25 Best Countries For A Comfortable Retirement"", ""summary"": ""In this article, we take a look at the 25 best countries for a comfortable retirement. You can skip our detailed analysis of the aging demographics and the resulting economic shifts and go directly to 10 Best Countries For A Comfortable Retirement. Retiree Population: By Numbers The UN estimates suggest that there are 703 million [\u2026]""}]",{}
6,2023-02-19,234.52267456054688,2023-02-26,227.8242645263672,-0.028561886592549324,D3,"[{""date"": ""20230219110400"", ""headline"": ""The next big wave of patent cliffs is ahead; expect biopharma M&A to rise \ufffd\ufffd\ufffd report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230219210056"", ""headline"": ""25 Best Countries For A Comfortable Retirement"", ""summary"": ""In this article, we take a look at the 25 best countries for a comfortable retirement. You can skip our detailed analysis of the aging demographics and the resulting economic shifts and go directly to 10 Best Countries For A Comfortable Retirement. Retiree Population: By Numbers The UN estimates suggest that there are 703 million [\u2026]""}, {""date"": ""20230220054347"", ""headline"": ""What To Expect From Bristol-Myers Squibb In 2023"", ""summary"": ""Bristol-Myers Squibb's primary focus is developing and commercializing innovative products in various therapeutic areas. Click here to read why BMY stock is a Buy.""}, {""date"": ""20230220080342"", ""headline"": ""Amgen: Re-Rating Seems Fair"", ""summary"": ""Amgen has seen a near 15% pullback since the Horizon acquisition was announced in December. See why I am still a bit cautious on AMGN stock.""}, {""date"": ""20230220140013"", ""headline"": ""Possible bearish signals as Amgen Inc. (NASDAQ:AMGN) insiders disposed of US$5.2m worth of stock"", ""summary"": ""In the last year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a substantial stake in the company which may have...""}, {""date"": ""20230220153456"", ""headline"": ""25 Most Profitable NASDAQ Stocks Today"", ""summary"": ""In this article, we will look at the 25 most profitable NASDAQ stocks today. If you want to explore similar stocks, you can also take a look at 10 Most Profitable NASDAQ Stocks Today. 2022 was one of the worst years for the NASDAQ, primarily because it is dominated by tech, and tech stocks crashed as [\u2026]""}, {""date"": ""20230221080100"", ""headline"": ""Top 5 4th Quarter Trades of Palouse Capital Management, Inc."", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230221080100"", ""headline"": ""Top 5 4th Quarter Trades of BERKSHIRE ASSET MANAGEMENT LLC/PA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230221112735"", ""headline"": ""Unusual Options Activity: BABA, INTC, F and 7 Others"", ""summary"": """"}, {""date"": ""20230221123220"", ""headline"": ""Bristol Myers: Looking Good For 2023"", ""summary"": ""Bristol Myers has seen a recent pullback in its share price, just like many other big pharma names. Check out why I'm bullish on BMY stock.""}, {""date"": ""20230221124500"", ""headline"": ""Mizuho Securities Remains a Hold on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230221163600"", ""headline"": ""Amgen Inc. stock falls Tuesday, still outperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.95% to $238.24 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230222101000"", ""headline"": ""Interesting AMGN Put And Call Options For October 20th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230222123000"", ""headline"": ""This Recession-Proof Company Has a Best-in-Class Dividend"", ""summary"": ""Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.""}, {""date"": ""20230222140000"", ""headline"": ""AMGEN ANNOUNCES CARDIOVASCULAR STUDY TO EVALUATE ASSOCIATION BETWEEN LIPOPROTEIN(a) AND CARDIOVASCULAR RISK IN AFRICAN AMERICANS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the African American Heart Study, in collaboration with the Association of Black Cardiologists (ABC) and the Morehouse School of Medicine (MSM), which will measure the association between Lipoprotein(a), or Lp(a), and atherosclerotic cardiovascular disease (ASCVD) in 5,000 African American individuals across the United States. ASCVD is defined as the buildup of cholesterol plaque in arteries and includes events such as heart attack and stroke.""}, {""date"": ""20230222163600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.87% to $236.16 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230222205133"", ""headline"": ""12 Most Profitable Pharmaceutical Stocks Now"", ""summary"": ""In this piece, we will take a look at 12 most profitable pharmaceutical stocks now. For more stocks, head on over to 5 Most Profitable Pharmaceutical Stocks Now. The pharmaceutical industry was the center of attention in 2020 and 2021 after the deadly coronavirus pandemic ravaged the globe and disrupted the way of living. As [\u2026]""}, {""date"": ""20230223013700"", ""headline"": ""Nicholas Ward`s Dividend Growth Portfolio: January 2023 Review"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230223023503"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: January 2023 Review"", ""summary"": ""My dividend income rose by 9.56% on a y/y basis during January. My portfolio's value rose by approximately 6.9%. Here's a review of my portfolio for January 2023.""}, {""date"": ""20230223054700"", ""headline"": ""Top dividend stocks picked using a UBS machine-learning model"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230223163600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.62% higher to $237.62 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230224010300"", ""headline"": ""Catalyst watch: Tesla event, Microsoft talks OpenAI, Rivian earnings and Chevron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230224163600"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 1.67% to $233.66 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230225030200"", ""headline"": ""Pharmas, medtechs dominate list of innovation leaders thanks to patents"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230225090710"", ""headline"": ""Regeneron: Innovation And Disruption Done Right"", ""summary"": ""Regeneron Pharmaceuticals' collaborative energy is strong and the medium-term looks good. Check out why we rate REGN stock a Hold for now.""}, {""date"": ""20230226102100"", ""headline"": ""M&A activity in the Americas cooled in 2022 amid ongoing macro uncertainty"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230226130047"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights The projected fair value for Amgen is US$371 based on 2 Stage Free Cash Flow to Equity Current share price...""}]",{}
7,2023-02-26,227.8242645263672,2023-03-05,228.94552612304688,0.004921607446031873,U1,"[{""date"": ""20230226102100"", ""headline"": ""M&A activity in the Americas cooled in 2022 amid ongoing macro uncertainty"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230226130047"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Shares Could Be 37% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights The projected fair value for Amgen is US$371 based on 2 Stage Free Cash Flow to Equity Current share price...""}, {""date"": ""20230227211157"", ""headline"": ""Top 10 Drug Companies in USA and Their China Reliance"", ""summary"": ""In this article, we will be taking a look at the top 10 drug companies in USA and their China reliance. To skip our detailed analysis of the pharmaceutical sector, you can go directly to see the Top 5 Drug Companies in USA and Their China Reliance. The US has long been reliant on China [\u2026]""}, {""date"": ""20230228040400"", ""headline"": ""The 20 worst U.S. stocks in February: the biggest loser dropped 35%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230228053200"", ""headline"": ""Stocks most and least liked by hedge funds and mutual funds -  Goldman"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230228071927"", ""headline"": ""Royalty Pharma: Strong Q4 Results, Reiterating A Buy Rating"", ""summary"": ""Royalty Pharma recently reported positive FY 2022 earnings. We like its focus on Lpa class. Read to know why we maintain a buy rating on RPRX stock.""}, {""date"": ""20230228121307"", ""headline"": ""Horizon Therapeutics: Attractive 5.4% Upside To Amgen Offer"", ""summary"": ""Horizon Therapeutics is a $25 billion biotech that's being acquired by Amgen Inc. Click for my review of the HZNP deal prospects.""}, {""date"": ""20230228163600"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slid 1.19% to $231.66 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230301022200"", ""headline"": ""Tracking John Paulson`s Paulson & Company Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230301032137"", ""headline"": ""Tracking John Paulson's Paulson & Company Portfolio - Q4 2022 Update"", ""summary"": ""John Paulson\u00e2\u0080\u0099s 13F portfolio value decreased from $1.37B to $1.11B this quarter. Read more about Paulson & Company's holdings and trades for Q4 2022.""}, {""date"": ""20230301061300"", ""headline"": ""Horizon Therapeutics reports Q4  EPS $1.21, consensus  $1.09"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230301080400"", ""headline"": ""Amgen to present new Repatha combined data from  Phase 3 FOURIER trials"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230301114553"", ""headline"": ""My $394k Portfolio Outperforms The Market Again In A Dreary February"", ""summary"": ""My portfolio, built specifically for my retirement ~20+ years from now, features growth, dividends, and risk stocks for a happy retirement. Click to read more.""}, {""date"": ""20230301134500"", ""headline"": ""3 Value Stocks You'll Regret Not Buying on the Dip"", ""summary"": ""Value stocks are poised for a strong decade.  The simple reason is that the Federal Reserve is highly unlikely to spur another growth stock boom by lowering interest rates to the effective floor in the years ahead.  Which value stocks are best positioned to capitalize on this favorable long-term dynamic?""}, {""date"": ""20230301140000"", ""headline"": ""AMGEN TO PRESENT NEW REPATHA\u00ae (EVOLOCUMAB) AND OLPASIRAN DATA AT ACC"", ""summary"": ""Amgen (NASDAQ: AMGN) today announced new Repatha\u00ae (evolocumab) combined data from the Phase 3 FOURIER and FOURIER Open Label Extension (OLE) studies and the Phase 2 OCEAN(a)-DOSE study of investigational olpasiran, an siRNA that reduces lipoprotein(a) [Lp(a)] by more than 90%. Additional data from Amgen's Center for Observational Research and Amgen funded investigator studies, including YELLOW-III from Mount Sinai will be presented at the American College of Cardiology's 72nd Annual Scientific S""}, {""date"": ""20230301163600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. rallied 1.96% to $236.19 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230302021600"", ""headline"": ""Barclays Sticks to Its Sell Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230302131446"", ""headline"": ""Amgen Inc. 2022 Q4 - Results - Earnings Call Presentation"", ""summary"": ""The following slide deck was published by Amgen Inc.""}, {""date"": ""20230302140029"", ""headline"": ""With 78% institutional ownership, Amgen Inc. (NASDAQ:AMGN) is a favorite amongst the big guns"", ""summary"": ""Key Insights Institutions' substantial holdings in Amgen implies that they have significant influence over the...""}, {""date"": ""20230302163004"", ""headline"": ""Why Is Amgen (AMGN) Down 4.2% Since Last Earnings Report?"", ""summary"": ""Amgen (AMGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.""}, {""date"": ""20230302163600"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slumped 0.61% to $234.74 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230302224510"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $234.74, moving -0.61% from the previous trading session.""}, {""date"": ""20230303012700"", ""headline"": ""March`s 17 Ideal 2023 Barrons/Bloomberg Dividend Dogs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230303014733"", ""headline"": ""Tracking George Soros's Portfolio - Q4 2022 Update"", ""summary"": ""George Soros' 13F portfolio value increased from $5.86B to $7.26B this quarter. Click here to read the Q4 2022 Update on Soros Fund Management's portfolio.""}, {""date"": ""20230303022556"", ""headline"": ""March's 17 Ideal 2023 Barrons/Bloomberg Dividend Dogs"", ""summary"": ""Ten top 2023 Bar/BI-projected dividend yields ranged from 4.78% to 7.94%. Click here for a detailed analysis.""}, {""date"": ""20230303075000"", ""headline"": ""Analysts` Opinions Are Mixed on These Healthcare Stocks: Amgen (AMGN) and Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230303110000"", ""headline"": ""Could This Humira Biosimilar Be a Winner for Amgen?"", ""summary"": ""At the end of January, Amgen (NASDAQ: AMGN) celebrated the U.S. launch of its biosimilar Amjevita to AbbVie's (NYSE: ABBV) star immunology drug called Humira.  Amgen's Amjevita received approval from the U.S. Food and Drug Administration (FDA) as a biosimilar in 2016.""}, {""date"": ""20230303113017"", ""headline"": ""7 Over-$100 Stocks That Are Worth Every Penny"", ""summary"": ""If searching out over-$100 stocks to buy seems arbitrary, take a step back and consider this. It\u2019s great to have a mix of stocks in your portfolio. There are all sorts of sizes and flavors of stocks from which to choose, including mega-cap stocks and even small-cap stocks. So it\u2019s understandable that when you\u2019re looking for stocks to buy, you may sometimes miss some obvious well-priced choices that are right in front of you. Some of the best names out there fall into the category of over-$100 st""}, {""date"": ""20230303125100"", ""headline"": ""Tracking George Soros`s Portfolio - Q4 2022 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230303140723"", ""headline"": ""12 Most Profitable Biotech Stocks Today"", ""summary"": ""In this article, we will discuss the 12 Most Profitable Biotech Stocks Today. You can skip our industry overview and go directly to the 5 Most Profitable Biotech Stocks Today. The term \u201cbiotechnology\u201d refers to the utilization of living organisms or biological systems to create solutions that address various agricultural, industrial, and health-related problems. The most [\u2026]""}, {""date"": ""20230303150900"", ""headline"": ""U.S. companies embark on record borrowing spree, despite paying highest rates since 2009"", ""summary"": ""Higher interest rates aren't deterring companies with high credit ratings from borrowing in the U.S. corporate bond market at a record clip in 2023.""}, {""date"": ""20230303163600"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.03% higher to $234.81 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230303210000"", ""headline"": ""AMGEN TO PRESENT AT THE 43RD ANNUAL TD COWEN HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 TD Cowen Healthcare Conference at 11:10 a.m. ET on Wednesday, March 8, 2023. Murdo Gordon, executive vice president of Global Commercial Operations and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230304035353"", ""headline"": ""My Dividend Growth Portfolio February Update: Cash Is Not Trash"", ""summary"": ""Cash is yielding over 4%, so a dividend growth investor can afford to be patient. Click here to read the February Update on my dividend growth portfolio.""}, {""date"": ""20230305001534"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of March 5"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""20230305101100"", ""headline"": ""Spectrum`s Rolvedon: An Undifferentiated, Small Player In A Vast Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230305102000"", ""headline"": ""Cantor biopharma/biotech analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230305230635"", ""headline"": ""Spectrum's Rolvedon: An Undifferentiated, Small Player In A Vast Market"", ""summary"": ""Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon. Read more to see why SPPI stock is a Sell.""}]",{}
8,2023-03-05,228.94552612304688,2023-03-12,222.17886352539062,-0.029555775612839508,D3,"[{""date"": ""20230305001534"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of March 5"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}, {""date"": ""20230305101100"", ""headline"": ""Spectrum`s Rolvedon: An Undifferentiated, Small Player In A Vast Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230305230635"", ""headline"": ""Spectrum's Rolvedon: An Undifferentiated, Small Player In A Vast Market"", ""summary"": ""Spectrum Pharmaceuticals develops and commercializes cancer therapies, including Rolvedon. Read more to see why SPPI stock is a Sell.""}, {""date"": ""20230306124900"", ""headline"": ""Merck to start phase 3 of oral PCSK9 inhibitor for cholesterol following mid-stage results"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230306170001"", ""headline"": ""Merck's drug boosts exercise capacity in pulmonary hypertension patients"", ""summary"": ""Merck & Co Inc said on Monday its experimental therapy, sotatercept, helped increase exercise capacity in patients with a deadly disease that causes high pressure in blood vessels of the heart and lungs in a late-stage study.  A second experimental heart drug, MK-0616, helped reduce levels of low-density lipoprotein (LDL) cholesterol by between 41.2% at a low 6 mg dose to 60.9% at a higher 30 mg dose in a mid-stage study, the drugmaker said.  Sotatercept, which Merck gained through its $11.5 billion buyout of Acceleron Pharma, combined with background therapy helped extend the distance that patients with pulmonary arterial hypertension could walk in six minutes by 40.8 meters.""}, {""date"": ""20230307033800"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230307063700"", ""headline"": ""Biden to announce plan to keep Medicare solvent beyond 2050"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230307085500"", ""headline"": ""Amgen declares $2.13 dividend"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230307100000"", ""headline"": ""High Yield Stock Watchlist: March 2023"", ""summary"": ""There are 17 stocks on my high-yield watchlist for March 2023. Read why the stocks on my watchlist are undervalued based on dividend yield theory.""}, {""date"": ""20230307210000"", ""headline"": ""AMGEN ANNOUNCES 2023 SECOND QUARTER DIVIDEND"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $2.13 per share dividend for the second quarter of 2023. The dividend will be paid on June 8, 2023, to all stockholders of record as of the close of business on May 18, 2023.""}, {""date"": ""20230308022100"", ""headline"": ""Noteworthy Wednesday Option Activity: AMGN, MET, LLY"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230308033800"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230308080145"", ""headline"": ""2 March Dogs Of The Dow To Buy, 4 More To Watch"", ""summary"": ""The highest-yield 10 are March\u00e2\u0080\u0099s Dogs of the Dow: JNJ, KO, CSCO, AMGN, CVX, DOW, IBM, WBA, MMM, and VZ, averaging a 4.41% annual yield.""}, {""date"": ""20230308101500"", ""headline"": ""A Bull Market Is Coming: 3 Stocks Near Their 52-Week Lows to Buy Now"", ""summary"": ""The stock market is struggling, but investors shouldn't bet against it in the long run.  Investing in stocks that are underperforming and that are good long-term investments, before a bull market arrives, can be a way to set yourself up for some great gains down the road.  Three stocks that are trading near 52-week lows that long-term investors should be eyeing right now are Amgen\u00a0(NASDAQ: AMGN),\u00a0Alphabet\u00a0(NASDAQ: GOOG) (NASDAQ: GOOGL), and Southern Company\u00a0(NYSE: SO).""}, {""date"": ""20230308111400"", ""headline"": ""Video: Daily Dividend Report: AMGN,JCI,AMOT,ZBH,FLXS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230308120030"", ""headline"": ""Amgen (NASDAQ:AMGN) Has A Pretty Healthy Balance Sheet"", ""summary"": ""David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...""}, {""date"": ""20230308132904"", ""headline"": ""Amgen Inc. (AMGN) Presents at 43rd Annual TD Cowen Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) 43rd Annual TD Cowen Healthcare Conference March 8, 2023 11:10 AM ETCompany ParticipantsPeter Griffith - Executive Vice President and Chief Financial...""}, {""date"": ""20230308224510"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $228.43, moving -0.13% from the previous trading session.""}, {""date"": ""20230309033700"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230309091706"", ""headline"": ""Amgen (AMGN) Declares $2.13 Dividend"", ""summary"": """"}, {""date"": ""20230309095500"", ""headline"": ""Cantor biopharma/biotech analysts to hold analyst/industry conference call"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230309144000"", ""headline"": ""New Drugs Are Coming to Market at Sky-High Prices"", ""summary"": ""A new  Amgen  lung-cancer treatment, Lumakras, carried a hefty price tag when it came out in 2021: $17,900 per patient monthly.  Just over a year later, in December 2022, a second drug for the same type of cancer, Krazati from  Mirati Therapeutics  had an even higher price: $19,750 a month\u2014a 10% premium.  As drugmakers face rising pressure to rein in repeat or annual price hikes on existing drugs, new brand-name medicines are coming to market with ever-higher price tags on day one.""}, {""date"": ""20230309172811"", ""headline"": ""Replimune: A Sell Ahead Of Cutaneous Squamous Cell Carcinoma Data"", ""summary"": ""Replimune's RP1 results are promising, but caution is warranted due to the limitations of the study. Learn why REPL stock is a 'Sell' & 'Short.'""}, {""date"": ""20230309214300"", ""headline"": ""New Drugs for Cancer, Rare Disease Can Now Cost More Than $20,000 a Month"", ""summary"": ""As drugmakers face pressure to rein in price hikes on existing drugs, new medicines arrive with ever-higher prices on day one, contributing to rising costs for patients and stretched budgets for insurers.""}, {""date"": ""20230309222000"", ""headline"": ""AMGEN TO PRESENT AT THE 33rd ANNUAL OPPENHEIMER HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 Oppenheimer Healthcare Conference at 2:00 p.m. ET on Monday, March 13, 2023. Susan Sweeney, senior vice president, Global Marketing, Access and Capabilities at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230310033500"", ""headline"": ""Mizuho Securities Sticks to Its Hold Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230310084653"", ""headline"": ""Assuming No-Growth, Gilead Is The Safest Choice Among The Large Biotechs"", ""summary"": ""Gilead has a strong credit profile and a low cost of equity. Find out why for an investor seeking relative safety, GILD stock is worth a look.""}, {""date"": ""20230310163600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.92% higher to $227.87 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230311090000"", ""headline"": ""The Near-Perfect Portfolio: Sleep Well During Turbulent Times"", ""summary"": ""With the economy going through the boom and bust cycles more frequently, the extreme ups and downs of the market are inevitable. Read more here.""}, {""date"": ""20230311122952"", ""headline"": ""Amgen's (NASDAQ:AMGN) Shareholders Will Receive A Bigger Dividend Than Last Year"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) has announced that it will be increasing its dividend from last year's comparable payment on...""}]",{}
9,2023-03-12,222.17886352539062,2023-03-19,224.0509033203125,0.008425823074335481,U1,"[{""date"": ""20230313041700"", ""headline"": ""Amgen upgraded to Overweight from Equal Weight at Wells Fargo"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313072600"", ""headline"": ""Wells Fargo upgrades Amgen to Overweight, lowers target to $265"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313091500"", ""headline"": ""Street Wrap: Today`s Top 15 Upgrades, Downgrades, Initiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313094900"", ""headline"": ""Amgen, Procter & Gamble share gains lead the way, but Dow flat"", ""summary"": ""The Dow Jones Industrial Average is flat Monday morning with shares of Amgen and Procter & Gamble seeing positive momentum for the price-weighted average....""}, {""date"": ""20230313095100"", ""headline"": ""Amgen, Procter & Gamble share gains lead Dow`s 90-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313105000"", ""headline"": ""Amgen, Procter & Gamble share gains lead Dow's 90-point climb"", ""summary"": ""Shares of Amgen and Procter & Gamble are trading higher Monday morning, sending the Dow Jones Industrial Average into positive territory. The Dow is trading...""}, {""date"": ""20230313105100"", ""headline"": ""Amgen upgraded at Wells Fargo citing a post-Horizon deal opportunity"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313105300"", ""headline"": ""Amgen facing class action suit over owing more than $10B in back taxes and penalties"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313115100"", ""headline"": ""Dow jumps nearly 200 points on gains for Amgen, Microsoft stocks"", ""summary"": ""Behind positive momentum for shares of Amgen and Microsoft, the Dow Jones Industrial Average is up Monday morning. The Dow was most recently trading 197...""}, {""date"": ""20230313125400"", ""headline"": ""Amgen, Microsoft share gains contribute to Dow`s nearly 100-point climb"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230313135300"", ""headline"": ""Amgen, Microsoft share gains contribute to Dow's nearly 100-point climb"", ""summary"": ""The Dow Jones Industrial Average is up Monday afternoon with shares of Amgen and Microsoft seeing positive momentum for the price-weighted average. Shares of...""}, {""date"": ""20230313152300"", ""headline"": ""Microsoft, Amgen share gains lead the way, but Dow flat"", ""summary"": ""The Dow Jones Industrial Average is flat Monday afternoon with shares of Microsoft and Amgen seeing positive growth for the price-weighted average. The Dow...""}, {""date"": ""20230313152706"", ""headline"": ""Amgen Inc. (AMGN) Oppenheimer 33rd Annual Healthcare Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Oppenheimer 33rd Annual Healthcare Conference March 13, 2023 2:00 PM ETCompany ParticipantsArvind Sood - Vice President, Investor RelationsSusan Sweeney -...""}, {""date"": ""20230313170541"", ""headline"": ""15 Biggest Retirement Mistakes You Will Regret Forever"", ""summary"": ""In this article, we take a look at the 15 biggest retirement mistakes you will regret forever. For more such retirement mistakes, go to 5 Biggest Retirement Mistakes You Will Regret Forever. Retirement is an inevitable stage in every individual\u2019s life. After working for several years, people eventually reach a point where they want to [\u2026]""}, {""date"": ""20230314010338"", ""headline"": ""Wells Fargo Upgrades Amgen (AMGN)"", ""summary"": """"}, {""date"": ""20230314072659"", ""headline"": ""Wall Street Breakfast Podcast: Report: Another Auction Of SVB"", ""summary"": ""FDIC is reportedly planning another auction of Silicon Valley Bank. Credit Suisse discloses 'material weakness' in reporting procedures. CPI watch: All eyes on inflation data.""}, {""date"": ""20230314094000"", ""headline"": ""Video: Dow Movers: AMGN, CRM"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230314134500"", ""headline"": ""2 Stocks to Buy Near Their 52-Week Lows That Could Help You Beat The Market"", ""summary"": ""Digging deeper, though, reveals that Amgen and Match Group both have excellent prospects.  Amgen has been dealing with declining sales of some of its key products, causing the company's revenue to grow, if at all, at a pretty modest pace.""}, {""date"": ""20230314151522"", ""headline"": ""Amgen is sued for concealing $10.7 billion tax bill from investors"", ""summary"": ""Amgen Inc has been sued in a proposed class action accusing the drugmaker of waiting too long to tell investors it might owe the Internal Revenue Service $10.7 billion in taxes and penalties.""}, {""date"": ""20230314163600"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 1.12% to $230.58 Tuesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230314204023"", ""headline"": ""Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B"", ""summary"": ""In a complaint filed in Manhattan federal court, a Detroit-based pension fund said Amgen Inc (NASDAQ: AMGN) concealed the dispute over its international tax strategy between July 2020 and April 2022 and had its investors wait for too long on disclosing taxes and penalties bill of $10.7 billion. The Internal Revenue Service (IRS) accused Amgen of underreporting taxes from 2010 to 2015 by inappropriately attributing its U.S. profits to a Puerto Rico subsidiary. Though Puerto Rico is a U.S. territo""}, {""date"": ""20230314215009"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $230.58 in the latest trading session, marking a -1.12% move from the prior day.""}, {""date"": ""20230315022005"", ""headline"": ""25 Biggest Pharmaceutical Companies in the World"", ""summary"": ""In this article, we will be taking a look at the 25 biggest pharmaceutical companies in the world. To skip our detailed analysis, you can go directly to see the 10 biggest pharmaceutical companies in the world. There is no need to emphasize the value of the pharmaceutical industry after the Covid-19 pandemic. Without the [\u2026]""}, {""date"": ""20230315133000"", ""headline"": ""2 Top Biotech Stocks to Buy Right Now"", ""summary"": ""A high dividend yield and powerful growth prospects are a rare combination for any single stock to offer.  On one hand, a high yield often comes with the trade-off of an elevated dividend payout ratio and lower resulting growth potential.  On the other hand, a company with adequate growth opportunities will generally have a lower payout ratio to retain the capital needed for growth.""}, {""date"": ""20230315163600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.87% to $234.90 Wednesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230315214509"", ""headline"": ""Amgen (AMGN) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $234.90, marking a +1.87% move from the previous day.""}, {""date"": ""20230316063114"", ""headline"": ""PBE: Healthcare Dashboard For March"", ""summary"": ""Healthcare equipment is the less attractive subsector regarding both valuation and quality. Click here to find out why PBE is a Hold.""}, {""date"": ""20230316090200"", ""headline"": ""Visa, Merck share losses lead Dow`s nearly 250-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230316105000"", ""headline"": ""Is It Time to Buy the Dow Jones' 3 Worst-Performing February (and Now March) Stocks?"", ""summary"": ""If you're a fan of buying beaten-up blue chip stocks, there's certainly no shortage of them now.  The Dow Jones Industrial Average (DJINDICES: ^DJI) is down nearly 8% from last month's high -- a sell-off that actually got going in mid-February.  Roughly half of the Dow's components are doing worse than the average -- and that can pose a tricky temptation for investors.""}, {""date"": ""20230316133832"", ""headline"": ""Buy And Hold Coffee Can Portfolio For The Next 15 Years"", ""summary"": ""This article covers topics from Christopher Mayer's book ""}, {""date"": ""20230316163600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.14% to $234.57 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230316233557"", ""headline"": ""BRIEF-Amgen Announces Workforce Reduction By About 450 Jobs"", ""summary"": ""* AMGEN - ANNOUNCED CHANGES THAT WILL RESULT IN A REDUCTION OF OUR WORKFORCE BY APPROXIMATELY 450 JOBS, REPRESENTING LESS THAN 2% OF OUR TOTAL WORKFORCE""}, {""date"": ""20230317004523"", ""headline"": ""UPDATE 2-Amgen to cut 450 jobs in second round of layoffs this year"", ""summary"": ""Amgen Inc said on Thursday it would cut 450 jobs, or less than 2% of its workforce, making it the company's second round of layoffs this year amid intensifying pressure on drug prices and high inflation.  \""We made these changes to realign our expense base in the face of intensifying pressure on drug prices and high levels of inflation,\"" a company spokeswoman said in a statement to Reuters.  The company had about 25,200 staff members in more than 50 countries as of Dec. 31, 2022, according to its latest annual regulatory filing with the U.S. Securities and Exchange Commission.""}, {""date"": ""20230317004746"", ""headline"": ""Amgen to cut 450 jobs in second round of layoffs this year"", ""summary"": ""\""We made these changes to realign our expense base in the face of intensifying pressure on drug prices and high levels of inflation,\"" a company spokeswoman said in a statement to Reuters.  The company had about 25,200 staff members in more than 50 countries as of Dec. 31, 2022, according to its latest annual regulatory filing with the U.S. Securities and Exchange Commission.  Amgen's decision to downsize its workforce underscores the impact of rapidly increasing interest rates on the healthcare industry.""}, {""date"": ""20230317030800"", ""headline"": ""Amgen to cut about 450 jobs in second round of layoffs this year"", ""summary"": ""Amgen Inc. on Thursday said it would lay off about 450 employees, or less than 2% of its workforce, as it faces increasing pressure from drug prices and high inflation.""}, {""date"": ""20230317031100"", ""headline"": ""Amgen (NASDAQ:AMGN) to Slash More Jobs in Second Round of Layoffs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230317035200"", ""headline"": ""More U.S. companies layoffs as Amgen deepens job cuts amid pressure on drug prices and inflations woes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230317041100"", ""headline"": ""More U.S. companies layoff as Amgen deepens job cuts amid pressure on drug prices and inflation woes"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230317094000"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN) and Acurx Pharmaceuticals (ACXP)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230317163600"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 2.04% to $229.79 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230319051800"", ""headline"": ""The Tao Of The Dow, Simple Self-Indexing Strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
10,2023-03-19,224.0509033203125,2023-03-26,232.08511352539062,0.03585886102673763,U4,"[{""date"": ""20230319051800"", ""headline"": ""The Tao Of The Dow, Simple Self-Indexing Strategy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230320024500"", ""headline"": ""Mirati`s Krazati: A Strong Competitor In The KRAS G12C-Mutated NSCLC Market"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230320034310"", ""headline"": ""Mirati's Krazati: A Strong Competitor In The KRAS G12C-Mutated NSCLC Market"", ""summary"": ""Mirati Therapeutics's Krazati could capture a significant share of the 2L KRAS G12C-mutated NSCLC market. Click here to read why MRTX stock is a Buy.""}, {""date"": ""20230320102300"", ""headline"": ""3 Dow Stocks Near 52-Week Lows That Look Like Bargains Now"", ""summary"": ""The past 15 months have been disastrous for the major stock market indexes, but one has fared better than its peers.  The Dow Jones Industrial Average has fallen around 12% since the end of 2021.  While traditionally filled with industrial and financial stocks, there aren't any specific rules that determine which companies become one of the Dow's 30 components.""}, {""date"": ""20230320144349"", ""headline"": ""3 Dow Jones Stocks To Watch Today"", ""summary"": ""Here are three Dow Jones stocks to keep on watch in the stock market now.""}, {""date"": ""20230320163600"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rose 2.15% to $234.72 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230320201208"", ""headline"": ""Top Analyst Reports for Alphabet, Tesla & Amgen"", ""summary"": ""Today's Research Daily features new research reports on 16 major stocks, including Alphabet Inc. (GOOGL), Tesla, Inc. (TSLA) and Amgen Inc. (AMGN).""}, {""date"": ""20230321013500"", ""headline"": ""Amgen Announces More Layoffs - Why I`d Buy This Dip"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230321020200"", ""headline"": ""Altimmune leads obesity drug developers lower after data for lead asset"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230321105700"", ""headline"": ""Nvidia unveils language models, generative AI service to help Life Sciences R&D"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230321114311"", ""headline"": ""The Zacks Analyst Blog Highlights Alphabet, Tesla, Amgen, FedEx and Capital One Financial"", ""summary"": ""Alphabet, Tesla, Amgen, FedEx and Capital One Financial are part of the Zacks top Analyst Blog.""}, {""date"": ""20230321142931"", ""headline"": ""Amgen Announces More Layoffs - Why I'd Buy This Dip"", ""summary"": ""Amgen expects to lay off 3% of its entire workforce before 1H 2023 - around 750 staff. Read why, despite the dour news, AMGN stock may be a buy at current levels.""}, {""date"": ""20230321152932"", ""headline"": ""Horizon Therapeutics: Attractive 7.16% Upside To Amgen Deal"", ""summary"": ""Horizon Therapeutics Public Limited Company is a $25 billion biotech Amgen Inc. is acquiring. Click here to read our view of the HZNP-AMGN deal.""}, {""date"": ""20230321163600"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slumped 0.75% to $232.95 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230321215009"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $232.95, marking a -0.75% move from the previous day.""}, {""date"": ""20230322095109"", ""headline"": ""Here's What is Driving Amgen (AMGN) Stock's Outperformance"", ""summary"": ""Amgen's (AMGN) key drugs like Prolia, Repatha and Otezla are driving sales. It is also rapidly advancing its robust pipeline.""}, {""date"": ""20230322140030"", ""headline"": ""Those who invested in Amgen (NASDAQ:AMGN) five years ago are up 59%"", ""summary"": ""While Amgen Inc. ( NASDAQ:AMGN ) shareholders are probably generally happy, the stock hasn't had particularly good run...""}, {""date"": ""20230322163600"", ""headline"": ""Amgen Inc. stock outperforms market despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slipped 1.34% to $229.83 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230322214509"", ""headline"": ""Amgen (AMGN) Stock Moves -1.34%: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $229.83, marking a -1.34% move from the previous day.""}, {""date"": ""20230323105100"", ""headline"": ""Interesting AMGN Put And Call Options For May 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230323110700"", ""headline"": ""See How Amgen Ranks Among Analysts` Top Dow 30 Picks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230323110700"", ""headline"": ""Video: Dow Analyst Moves: AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230323163600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.42% to $233.10 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230324014700"", ""headline"": ""Amgen, Procter & Gamble share gains contribute to Dow`s 100-point jump"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324042200"", ""headline"": ""Amgen: Questioning The Horizon Therapeutics Acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324060200"", ""headline"": ""Amgen: Revenue Growth Potentials And Financial Performance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324070800"", ""headline"": ""Mizuho Securities Keeps Their Hold Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324120400"", ""headline"": ""FDA draft guidance impacts companies using accelerated approval for oncology drugs"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230324124700"", ""headline"": ""Amgen, Procter & Gamble share gains lead the way, but Dow flat"", ""summary"": ""Shares of Amgen and Procter & Gamble are seeing positive growth Friday afternoon, though the Dow Jones Industrial Average remains roughly flat. The Dow is...""}, {""date"": ""20230324144600"", ""headline"": ""Amgen, Procter & Gamble share gains contribute to Dow's 100-point jump"", ""summary"": ""Powered by strong returns for shares of Amgen and Procter & Gamble, the Dow Jones Industrial Average is climbing Friday afternoon. Shares of Amgen and...""}, {""date"": ""20230324163600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 2.11% to $238.03 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230324181828"", ""headline"": ""Final Trades: AMGN, FHN, MLPX & WMT"", ""summary"": ""The final trades of the week. With CNBC's Melissa Lee and the Fast Money traders, Steve Grasso, Courtney Garcia, Tim Seymour and Guy Adami.""}]",{}
11,2023-03-26,232.08511352539062,2023-04-02,235.7122039794922,0.015628277053214568,U2,"[{""date"": ""20230327100000"", ""headline"": ""Amgen bid to revive cholesterol drug patents comes to U.S. Supreme Court"", ""summary"": ""The U.S. Supreme Court on Monday is set to hear a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a \""blatant attempt\"" to squeeze competitors out of the market.  Amgen is appealing a lower court's ruling that invalidated two of its patents on Repatha, a drug that can reduce risk of heart attack and stroke in people with heart disease, after a legal fight with French drugmaker Sanofi and its partner Regeneron Pharmaceuticals Inc.""}, {""date"": ""20230327125000"", ""headline"": ""Supreme Court hears arguments in Amgen Repatha patent case against Sanofi"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230327143502"", ""headline"": ""UPDATE 1-U.S. Supreme Court hears Amgen bid to revive cholesterol drug patents"", ""summary"": ""The U.S. Supreme Court on Monday began hearing a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a \""blatant attempt\"" to squeeze competitors out of the market.  Amgen is appealing a lower court's ruling that invalidated two of its patents on Repatha, a drug that can reduce risk of heart attack and stroke in people with heart disease, after a legal fight with French drugmaker Sanofi and its partner Regeneron Pharmaceuticals Inc.""}, {""date"": ""20230327161209"", ""headline"": ""U.S. Supreme Court mulls Amgen bid to revive cholesterol drug patents"", ""summary"": ""U.S. Supreme Court justices on Monday weighed a bid by Amgen Inc to revive patents on its cholesterol-lowering drug Repatha in a legal effort that rival Sanofi SA called a \""blatant attempt\"" to squeeze competitors out of the market.""}, {""date"": ""20230327163600"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 0.53% to $236.76 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230327231623"", ""headline"": ""Amgen-Sanofi patent case divides makers of antibody drugs"", ""summary"": ""Amgen Inc's battle with Sanofi and Regeneron at the U.S. Supreme Court over its cholesterol drug Repatha on Monday has some drugmakers hoping a ruling will reshape U.S. patent law and competition among companies that make antibody medicines.""}, {""date"": ""20230328052600"", ""headline"": ""Amgen (AMGN) Receives a Hold from SVB Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230328163600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.73% higher to $238.48 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230328215009"", ""headline"": ""Amgen (AMGN) Gains As Market Dips: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $238.48 in the latest trading session, marking a +0.73% move from the prior day.""}, {""date"": ""20230329031600"", ""headline"": ""Viridian Therapeutics initiated with a Buy at Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230329043200"", ""headline"": ""Amgen, AstraZeneca`s asthma therapy Tezspire gets UK`s NICE backing"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230329095300"", ""headline"": ""WHO to weigh adding obesity therapies to `essential` medicines list \ufffd\ufffd\ufffd Reuters"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230329110132"", ""headline"": ""Selling US$5.2m worth of stock earlier this year was a lucrative decision for Amgen Inc. (NASDAQ:AMGN) insiders"", ""summary"": ""Even though Amgen Inc. ( NASDAQ:AMGN ) stock gained 3.8% last week, insiders who sold US$5.2m worth of stock over the...""}, {""date"": ""20230329163600"", ""headline"": ""Amgen Inc. stock rises Wednesday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. rallied 1.07% to $241.03 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230330113000"", ""headline"": ""This Blue Chip Dividend Stock Should Return to Form When the Risk Premium Flips"", ""summary"": ""T-bills may be the flavor of the month, but history has shown this top biotech stock is a far better long-term investment.""}, {""date"": ""20230330130001"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.""}, {""date"": ""20230330163600"", ""headline"": ""Amgen Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.19% higher to $241.50 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230331074100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN) and Eledon Pharmaceuticals (ELDN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230331133700"", ""headline"": ""1 Dividend Growth Stock to Buy Hand Over Fist"", ""summary"": ""Investing in dividend stocks, particularly those that raise their payouts regularly, can pay off massively in time.""}, {""date"": ""20230331140000"", ""headline"": ""My Top 10 High Dividend Yield Stocks To Invest In April 2023"", ""summary"": ""In today\u00e2\u0080\u0099s article, I will present you with my top 10 high Dividend Yield stocks to invest in for April 2023. Read more here.""}, {""date"": ""20230331163600"", ""headline"": ""Amgen Inc. stock rises Friday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.10% higher to $241.75 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230331214509"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $241.75, moving +0.1% from the previous trading session.""}, {""date"": ""20230402090200"", ""headline"": ""Seagen/Pfizer deal spread becoming increasingly attractive, analyst says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3784, ""bookValue"": 5348, ""cashRatio"": 2.2201899402040097, ""currentRatio"": 3.1448, ""ebitPerShare"": 3.7807, ""eps"": 5.2807, ""ev"": 159129.5, ""fcfMargin"": 0.1179, ""fcfPerShareTTM"": 14.103, ""grossMargin"": 0.7245, ""inventoryTurnoverTTM"": 1.3855, ""longtermDebtTotalAsset"": 0.6849, ""longtermDebtTotalCapital"": 0.9077, ""longtermDebtTotalEquity"": 11.3614, ""netDebtToTotalCapital"": 0.4487, ""netDebtToTotalEquity"": 5.6161, ""netMargin"": 0.4654, ""operatingMargin"": 0.3332, ""payoutRatioTTM"": 0.5372, ""pb"": 24.1388, ""peTTM"": 16.306, ""pfcfTTM"": 17.1417, ""pretaxMargin"": 0.5638, ""psTTM"": 4.9292, ""quickRatio"": 2.7923, ""receivablesTurnoverTTM"": 4.8442, ""roaTTM"": 0.1144, ""roeTTM"": 2.0999, ""roicTTM"": 0.1659, ""rotcTTM"": 0.1924, ""salesPerShare"": 11.3476, ""sgaToSale"": 0.2755, ""totalDebtToEquity"": 11.5174, ""totalDebtToTotalAsset"": 0.6943, ""totalDebtToTotalCapital"": 0.9201, ""totalRatio"": 1.0641, ""period"": ""2023-03-31""}"
12,2023-04-02,235.7122039794922,2023-04-09,246.99325561523438,0.04785942961495393,U5,"[{""date"": ""20230402090200"", ""headline"": ""Seagen/Pfizer deal spread becoming increasingly attractive, analyst says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230403041214"", ""headline"": ""A March ~6% Gain In My 25 Stock $417k Portfolio Beats The Market For The Third Time In 2023"", ""summary"": ""My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends, and risk stocks for a happy retirement. Click here for a detailed analysis.""}, {""date"": ""20230403093900"", ""headline"": ""3 Dow Stocks With Above-Average Dividends Yields to Buy in April"", ""summary"": ""Income-seeking investors are going to love the annual payout raises and yields of 2.9% or better that these legendary dividend payers offer right now.""}, {""date"": ""20230403160420"", ""headline"": ""High Yield Stock Watchlist: April 2023"", ""summary"": ""Click to see 19 stocks on my high-yield watchlist for April 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory.""}, {""date"": ""20230403163600"", ""headline"": ""Amgen Inc. stock rises Monday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rallied 1.11% to $244.44 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230403180400"", ""headline"": ""Dogs Of The Dow Stumble In First Quarter"", ""summary"": ""The Dogs of the Dow strategy has the sole focus of investing in the highest dividend-yielding stocks in the Dow Jones Industrial Average Index.""}, {""date"": ""20230404073100"", ""headline"": ""Analysts Are Bullish on These Healthcare Stocks: Amgen (AMGN), OncoCyte (OCX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230404130001"", ""headline"": ""Why Investors Need to Take Advantage of These 2 Medical Stocks Now"", ""summary"": ""Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.""}, {""date"": ""20230404161004"", ""headline"": ""Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?"", ""summary"": ""Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.""}, {""date"": ""20230404163600"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rallied 1.26% to $247.53 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230404190646"", ""headline"": ""April Dogs Of The Dow: 2 Buy, 3 Watch"", ""summary"": ""The highest-yield 10 stocks are April\u00e2\u0080\u0099s Dogs of the Dow: CSCO, GS, JPM, AMGN, CVX, IBM, DOW, WBA, MMM, VZ, averaging a 4.44% annual yield. Click here for our lists.""}, {""date"": ""20230404220145"", ""headline"": ""Tracking Baker Brothers Portfolio - Q4 2022 Update"", ""summary"": ""Baker Brothers\u00e2\u0080\u0099 13F portfolio value increased from $15.27B to $16.65B this quarter. Click here to see the Q4 2022 update on the portfolio.""}, {""date"": ""20230405085500"", ""headline"": ""Early notable gainers among liquid option names on April 5th"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230405094800"", ""headline"": ""Dow up nearly 100 points on gains for Johnson & Johnson, Amgen stocks"", ""summary"": ""The Dow Jones Industrial Average is climbing Wednesday morning with shares of Johnson & Johnson and Amgen leading the way for the index. Shares of Johnson &...""}, {""date"": ""20230405102651"", ""headline"": ""Amgen's (NASDAQ:AMGN) Upcoming Dividend Will Be Larger Than Last Year's"", ""summary"": ""Amgen Inc. ( NASDAQ:AMGN ) has announced that it will be increasing its dividend from last year's comparable payment on...""}, {""date"": ""20230405103500"", ""headline"": ""InflaRx upgraded to Buy at Guggenheim after Gohibic gets COVID EUA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230405104100"", ""headline"": ""AMGN Makes Bullish Cross Above Critical Moving Average"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230405105800"", ""headline"": ""AbbVie downgraded to hold at Argus on Humira competition in US"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230405130603"", ""headline"": ""3 Must-Buy Dow Stocks for Your April Buy List"", ""summary"": ""The Dow is short for the Dow Jones Industrial Average, a stock index that tracks the largest highly-traded public companies. It is one of the most watched indicators of overall stock market direction and includes 30 of the largest publicly traded firms. Thus, Dow stocks tend to get their fair share of attention from investors, due to their size and importance to the economy. The Dow represents the most significant industrial components of the U.S. economy. Thus, this index is often viewed as a w""}, {""date"": ""20230405163600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. advanced 2.36% to $253.37 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones...""}, {""date"": ""20230406044000"", ""headline"": ""7 Very Undervalued Penny Stocks to Buy in April 2023"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230406094400"", ""headline"": ""Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years"", ""summary"": ""While there are thousands of publicly traded companies available, not all are worth putting your hard-earned money into.  One of the more objective measures of quality in investing is a track record of outsized dividend growth.  Here are two dividend payers in the healthcare sector that have achieved huge payout growth in the past 10 years.""}, {""date"": ""20230406100900"", ""headline"": ""Morgan Stanley cuts Comcast, adds Becton Dickinson to its model portfolio"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230406113800"", ""headline"": ""FDA forces pre-term birth drug off the market after 12 years"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230406115700"", ""headline"": ""Nicholas Ward`s Dividend Growth Portfolio: Special Fixed Income Edition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230406163600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.02% to $253.32 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230406215009"", ""headline"": ""Amgen (AMGN) Stock Sinks As Market Gains: What You Should Know"", ""summary"": ""Amgen (AMGN) closed at $253.35 in the latest trading session, marking a -0.01% move from the prior day.""}, {""date"": ""20230407005614"", ""headline"": ""Nicholas Ward's Dividend Growth Portfolio: Special Fixed Income Edition"", ""summary"": ""My passive income stream grew by 22.63% in February and by 46.87% in March. Read more as I review my February and March results in this piece.""}, {""date"": ""20230407011700"", ""headline"": ""Catalyst Watch: Eyes on inflation data, big bank earnings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230407084500"", ""headline"": ""Mizuho Securities Keeps Their Hold Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230407085200"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Alnylam Pharma (ALNY), Amgen (AMGN) and Regeneron (REGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230408012000"", ""headline"": ""Week In Review: Suzhou Duality Out-Licenses Two ADCs To BioNTech In $1.7 Billion Deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230409092700"", ""headline"": ""Love Dividends? These 3 Stocks Are Smart Buys Right Now"", ""summary"": ""Receiving cash payments every three months is one obvious attraction.  If you're looking for businesses that can make and raise dividend payments regardless of an uncooperative economic environment, it's hard to do better than the healthcare sector.  While you're most likely familiar with CVS Health's (NYSE: CVS) chain of retail pharmacies, most don't realize that retail is a small part of this company's overall business.""}, {""date"": ""20230409110100"", ""headline"": ""Premier cancer research event, AACR is starting this week; Here is what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]","{""assetTurnoverTTM"": 0.3784, ""bookValue"": 5348, ""cashRatio"": 2.2201899402040097, ""currentRatio"": 3.1448, ""ebitPerShare"": 3.7807, ""eps"": 5.2807, ""ev"": 159129.5, ""fcfMargin"": 0.1179, ""fcfPerShareTTM"": 14.103, ""grossMargin"": 0.7245, ""inventoryTurnoverTTM"": 1.3855, ""longtermDebtTotalAsset"": 0.6849, ""longtermDebtTotalCapital"": 0.9077, ""longtermDebtTotalEquity"": 11.3614, ""netDebtToTotalCapital"": 0.4487, ""netDebtToTotalEquity"": 5.6161, ""netMargin"": 0.4654, ""operatingMargin"": 0.3332, ""payoutRatioTTM"": 0.5372, ""pb"": 24.1388, ""peTTM"": 16.306, ""pfcfTTM"": 17.1417, ""pretaxMargin"": 0.5638, ""psTTM"": 4.9292, ""quickRatio"": 2.7923, ""receivablesTurnoverTTM"": 4.8442, ""roaTTM"": 0.1144, ""roeTTM"": 2.0999, ""roicTTM"": 0.1659, ""rotcTTM"": 0.1924, ""salesPerShare"": 11.3476, ""sgaToSale"": 0.2755, ""totalDebtToEquity"": 11.5174, ""totalDebtToTotalAsset"": 0.6943, ""totalDebtToTotalCapital"": 0.9201, ""totalRatio"": 1.0641, ""period"": ""2023-03-31""}"
13,2023-04-09,246.99325561523438,2023-04-16,243.7561492919922,-0.01310605147974142,D2,"[{""date"": ""20230409092700"", ""headline"": ""Love Dividends? These 3 Stocks Are Smart Buys Right Now"", ""summary"": ""Receiving cash payments every three months is one obvious attraction.  If you're looking for businesses that can make and raise dividend payments regardless of an uncooperative economic environment, it's hard to do better than the healthcare sector.  While you're most likely familiar with CVS Health's (NYSE: CVS) chain of retail pharmacies, most don't realize that retail is a small part of this company's overall business.""}, {""date"": ""20230409110100"", ""headline"": ""Premier cancer research event, AACR is starting this week; Here is what to expect"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230410033000"", ""headline"": ""Diving Into the Smead Value Fund`s Top Holdings as Value Conference Approaches"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230410091400"", ""headline"": ""Horizon posts positive Phase 4 data for thyroid eye disease therapy Tepezza"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230410163600"", ""headline"": ""Amgen Inc. stock falls Monday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slumped 0.96% to $250.90 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230411032500"", ""headline"": ""Barclays Keeps Their Sell Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230411104752"", ""headline"": ""Stable growth companies aren't priced in to this market: Goldman's David Kostin"", ""summary"": ""David Kostin, Goldman Sachs Chief U.S. Equity Strategist, joins 'Squawk on the Street' to give his thoughts on the upcoming earnings season, where the surprises will be, and more.""}, {""date"": ""20230411140018"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) is a favorite amongst institutional investors who own 78%"", ""summary"": ""Key Insights Given the large stake in the stock by institutions, Amgen's stock price might be vulnerable to their...""}, {""date"": ""20230411163600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.21% higher to $251.43 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230412001100"", ""headline"": ""DivHut Portfolio Update: March 2023"", ""summary"": ""The system is clearly broken, and has been for a while; however, I could find comfort in one thing, my dividends. Four figures in a month is a win in my book.""}, {""date"": ""20230412022628"", ""headline"": ""Why Healthcare Stocks Are A Prescription For Investors In Q2 2023"", ""summary"": ""The recent drop in biopharma stocks presents a buying opportunity for investors. Find out why XLV seems like the best fit.""}, {""date"": ""20230412163600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.77% to $249.50 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230412202057"", ""headline"": ""Medical research has driven 'the last 200 years of economic expansion': Michael Milken"", ""summary"": ""Health investment and innovation has been on a roller coaster as a result of the pandemic. But the momentum needs to continue, according to Michael Milken.""}, {""date"": ""20230413081200"", ""headline"": ""Editas Medicine appoints Reeve as Chair of Board, Levy as new director"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230413160000"", ""headline"": ""How Horizon Therapeutics sold to Amgen for $27.8 billion without ever licensing a drug of its own"", ""summary"": ""Horizon grew large by snapping up cheap drugs from other companies, marketing them to perfection, and jacking up prices.""}, {""date"": ""20230413163600"", ""headline"": ""Amgen Inc. stock rises Thursday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.78% higher to $251.44 Thursday, on what proved to be an all-around favorable trading session for the stock market, with the S&P...""}, {""date"": ""20230413215009"", ""headline"": ""Amgen (AMGN) Gains But Lags Market: What You Should Know"", ""summary"": ""Amgen (AMGN) closed the most recent trading day at $251.44, moving +0.78% from the previous trading session.""}, {""date"": ""20230414032500"", ""headline"": ""Amgen (AMGN) Receives a Sell from Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414043100"", ""headline"": ""Amgen price target lowered to $227 from $230 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414043700"", ""headline"": ""Ghana 1st in world to approve new malaria vaccine by Oxford"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414074600"", ""headline"": ""Amgen (AMGN) Receives a Hold from Mizuho Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414075000"", ""headline"": ""Horizon announces FDA label update for thyroid eye disease therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230414163600"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.57% to $250.00 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230414215403"", ""headline"": ""Barclays Maintains Amgen (AMGN) Underweight Recommendation"", ""summary"": """"}, {""date"": ""20230416050050"", ""headline"": ""Better Buy For Retiring With Dividends: VYM Or SCHD?"", ""summary"": ""VYM and SCHD provide an all-in-one solution by offering attractive and growing dividend income streams. Check out which is the better buy at the moment.""}, {""date"": ""20230416092100"", ""headline"": ""Is Arrowhead Pharmaceuticals a Buy Now?"", ""summary"": ""The clinical-stage drug developer is attracting a lot of positive attention from investment bank analysts.""}, {""date"": ""20230416185257"", ""headline"": ""7 Dividend Stocks to Buy That Are Backed by Strong Cash Flows"", ""summary"": ""Many investors have heard the phrase \u201ccash is king\u201d relative to the current banking crisis. But it also has significance for dividend investors. A company\u2019s cash flow, and particularly its free cash flow, is an important indicator for investors trying to determine how safe a dividend payout is. This article highlights seven dividend stocks with strong cash flows. And I\u2019ve put an emphasis on free cash flow. Free cash flow is simply the money a company has left (or free to use) after it has paid o""}, {""date"": ""20230416222000"", ""headline"": ""Merck to Acquire Prometheus Biosciences"", ""summary"": ""Merck  & Co. said it agreed to acquire  Prometheus Biosciences  for $10.8 billion, a push into the lucrative market for immune-disease treatments.  Merck said Sunday it would acquire Prometheus at $200 a share, a roughly 75% premium to where shares closed on Friday, at $114.01.  The Wall Street Journal reported earlier Sunday that Merck was in late-stage talks with Prometheus for an acquisition.""}]","{""assetTurnoverTTM"": 0.3784, ""bookValue"": 5348, ""cashRatio"": 2.2201899402040097, ""currentRatio"": 3.1448, ""ebitPerShare"": 3.7807, ""eps"": 5.2807, ""ev"": 159129.5, ""fcfMargin"": 0.1179, ""fcfPerShareTTM"": 14.103, ""grossMargin"": 0.7245, ""inventoryTurnoverTTM"": 1.3855, ""longtermDebtTotalAsset"": 0.6849, ""longtermDebtTotalCapital"": 0.9077, ""longtermDebtTotalEquity"": 11.3614, ""netDebtToTotalCapital"": 0.4487, ""netDebtToTotalEquity"": 5.6161, ""netMargin"": 0.4654, ""operatingMargin"": 0.3332, ""payoutRatioTTM"": 0.5372, ""pb"": 24.1388, ""peTTM"": 16.306, ""pfcfTTM"": 17.1417, ""pretaxMargin"": 0.5638, ""psTTM"": 4.9292, ""quickRatio"": 2.7923, ""receivablesTurnoverTTM"": 4.8442, ""roaTTM"": 0.1144, ""roeTTM"": 2.0999, ""roicTTM"": 0.1659, ""rotcTTM"": 0.1924, ""salesPerShare"": 11.3476, ""sgaToSale"": 0.2755, ""totalDebtToEquity"": 11.5174, ""totalDebtToTotalAsset"": 0.6943, ""totalDebtToTotalCapital"": 0.9201, ""totalRatio"": 1.0641, ""period"": ""2023-03-31""}"
14,2023-04-16,243.7561492919922,2023-04-23,237.76951599121094,-0.024559927280480398,D3,"[{""date"": ""20230416050050"", ""headline"": ""Better Buy For Retiring With Dividends: VYM Or SCHD?"", ""summary"": ""VYM and SCHD provide an all-in-one solution by offering attractive and growing dividend income streams. Check out which is the better buy at the moment.""}, {""date"": ""20230416092100"", ""headline"": ""Is Arrowhead Pharmaceuticals a Buy Now?"", ""summary"": ""The clinical-stage drug developer is attracting a lot of positive attention from investment bank analysts.""}, {""date"": ""20230416185257"", ""headline"": ""7 Dividend Stocks to Buy That Are Backed by Strong Cash Flows"", ""summary"": ""Many investors have heard the phrase \u201ccash is king\u201d relative to the current banking crisis. But it also has significance for dividend investors. A company\u2019s cash flow, and particularly its free cash flow, is an important indicator for investors trying to determine how safe a dividend payout is. This article highlights seven dividend stocks with strong cash flows. And I\u2019ve put an emphasis on free cash flow. Free cash flow is simply the money a company has left (or free to use) after it has paid o""}, {""date"": ""20230416222000"", ""headline"": ""Merck to Acquire Prometheus Biosciences"", ""summary"": ""Merck  & Co. said it agreed to acquire  Prometheus Biosciences  for $10.8 billion, a push into the lucrative market for immune-disease treatments.  Merck said Sunday it would acquire Prometheus at $200 a share, a roughly 75% premium to where shares closed on Friday, at $114.01.  The Wall Street Journal reported earlier Sunday that Merck was in late-stage talks with Prometheus for an acquisition.""}, {""date"": ""20230417045000"", ""headline"": ""Bassem Elmankabadi, M.D. joins Foresee Pharmaceuticals as a Senior Vice President of Clinical Development"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230417110000"", ""headline"": ""Amgen Has Long-Term Staying Power"", ""summary"": """"}, {""date"": ""20230417125033"", ""headline"": ""15 Cheapest Countries for Retirement"", ""summary"": ""In this article, we will explore the 15 cheapest countries for retirement. You can skip our detailed analysis and go directly to 5 Cheapest Countries for Retirement. The Costs of Living in Retirement On average, a comfortable retirement in the USA costs an estimated $1 million. With Americans spending $50,220 annually post-retirement, 25% have already [\u2026]""}, {""date"": ""20230417155217"", ""headline"": ""Johnson & Johnson: 4 Key Areas Of Focus Ahead Of Q1 Earnings"", ""summary"": """"}, {""date"": ""20230417163600"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.77% to $248.07 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230418050200"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN), Resmed (RMD) and Travere Therapeutics (TVTX)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230418120023"", ""headline"": ""These 4 Measures Indicate That Amgen (NASDAQ:AMGN) Is Using Debt Reasonably Well"", ""summary"": ""Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...""}, {""date"": ""20230418163700"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. slid 0.80% to $246.09 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230419032100"", ""headline"": ""Amgen wins appeals court ruling in patent dispute over psoriasis drug Otezla"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230419034700"", ""headline"": ""Amgen wins patent appeal on Otezla"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230419163600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.05% higher to $246.21 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500...""}, {""date"": ""20230419171742"", ""headline"": ""Amgen wins appeal in US patent case over generic psoriasis drugs"", ""summary"": ""Amgen Inc convinced a U.S. appeals court on Wednesday to uphold patents that barred generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals and Novartis' Sandoz Inc.""}, {""date"": ""20230419204500"", ""headline"": ""AMGEN WINS PATENT APPEAL ON OTEZLA\u00ae (APREMILAST)"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that the U.S. Court of Appeals for the Federal Circuit has affirmed the judgment of the U.S. District Court for the District of New Jersey in a patent infringement lawsuit against Sandoz Inc. (\""Sandoz\"") and Zydus Pharmaceuticals (USA), Inc. (\""Zydus\""). Today's decision affirms the permanent injunction entered by the district court prohibiting Sandoz and Zydus from making, using, selling, offering to sell, or importing each of their generic versions of Otezla un""}, {""date"": ""20230419213822"", ""headline"": ""UPDATE 1-US Amgen ruling keeps generic psoriasis drug off market until 2028"", ""summary"": ""Amgen Inc convinced a U.S. appeals court on Wednesday to uphold patents that bar generic versions of its blockbuster psoriasis drug Otezla proposed by Zydus Pharmaceuticals and Novartis AG's Sandoz Inc until 2028.  The U.S. Court of Appeals for the Federal Circuit affirmed a New Jersey federal court's ruling that Amgen patents covering the drug were valid and that the proposed generics would infringe them.  The Federal Circuit also upheld a decision to invalidate one of Amgen's patents that Sandoz said would have barred its generics until 2034.""}, {""date"": ""20230419215009"", ""headline"": ""Amgen (AMGN) Gains As Market Dips: What You Should Know"", ""summary"": ""In the latest trading session, Amgen (AMGN) closed at $246.21, marking a +0.05% move from the previous day.""}, {""date"": ""20230420021600"", ""headline"": ""Amgen (AMGN) Receives a Sell from Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230420042600"", ""headline"": ""Amgen (NASDAQ:AMGN) Wins Patent Appeal on Key Psoriasis Drug"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230420121200"", ""headline"": ""See Which Of The Latest 13F Filers Holds Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230420121312"", ""headline"": ""Amgen (AMGN) Wins Patent Appeal for Blockbuster Psoriasis Drug"", ""summary"": ""The Appeal Court's decision upholding the patents for Amgen's (AMGN) blockbuster psoriasis drug Otezla will prevent drug-makers from selling a generic version till February 2028.""}, {""date"": ""20230420140302"", ""headline"": ""Amgen (AMGN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?"", ""summary"": ""Amgen (AMGN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.""}, {""date"": ""20230420163600"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 1.12% to $243.46 Thursday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230421024900"", ""headline"": ""VMware/Broadcom deal spread widens amid notice of FTC closed door meetings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230421070600"", ""headline"": ""Amgen (AMGN) Receives a Hold from Mizuho Securities"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230421111341"", ""headline"": ""XBI: Uncorrelated Growth Capitalizing On The M&A Tidal Wave In Pharma"", ""summary"": """"}, {""date"": ""20230421161642"", ""headline"": ""12 Best Pharma Dividend Stocks To Buy in 2023"", ""summary"": ""In this article, we discuss 12 best pharma dividend stocks to buy in 2023. You can skip our detailed analysis of the pharmaceutical sector and its outlook this year, and go directly to read 5 Best Pharma Dividend Stocks To Buy in 2023. The pharmaceutical industry in the US is one of the largest in [\u2026]""}, {""date"": ""20230421163600"", ""headline"": ""Amgen Inc. stock rises Friday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.16% higher to $243.86 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P...""}, {""date"": ""20230421170756"", ""headline"": ""11 Best Fast Money Stocks To Buy According To Hedge Funds"", ""summary"": ""In this article, we will discuss the 11 best Fast Money stocks to buy now according to hedge funds. If you want to explore similar stocks, you can also take a look at 5 Best Fast Money Stocks To Buy According To Hedge Funds. \u201cTrendlines Over Headlines\u201d On April 12 Piper Sandler\u2019s chief market technician, [\u2026]""}, {""date"": ""20230421200000"", ""headline"": ""AMGEN ANNOUNCES WEBCAST OF 2023 FIRST QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Thursday, April 27, 2023, after the close of the U.S. financial markets. The announcement will be followed by a conference call with the investment community at 1:30 p.m. PT. Participating in the call from Amgen will be Robert A. Bradway, chairman and chief executive officer, and other members of Amgen's senior management team.""}, {""date"": ""20230421225700"", ""headline"": ""China\u2019s Consumer-Led Growth Looks More Like a Bounce, Not a Recovery"", ""summary"": ""China\u2019s first-quarter GDP grew faster than expected after a Covid-racked 2022. But some strategists question whether it has the strength to drive a sustainable recovery.""}, {""date"": ""20230423001500"", ""headline"": ""ClearBridge SMID Cap Growth Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""20230423061500"", ""headline"": ""Nautilus Biotechnology: The Rubber Will Soon Meet The Road"", ""summary"": """"}, {""date"": ""20230423130021"", ""headline"": ""Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 59% gain"", ""summary"": ""If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...""}]",{}
15,2023-04-23,237.76951599121094,2023-04-30,233.75241088867188,-0.01689495428290122,D2,"[{""date"": ""20230423001500"", ""headline"": ""ClearBridge SMID Cap Growth Strategy Q1 2023 Portfolio Manager Commentary"", ""summary"": """"}, {""date"": ""20230423061500"", ""headline"": ""Nautilus Biotechnology: The Rubber Will Soon Meet The Road"", ""summary"": """"}, {""date"": ""20230423130021"", ""headline"": ""Investing in Amgen (NASDAQ:AMGN) five years ago would have delivered you a 59% gain"", ""summary"": ""If you buy and hold a stock for many years, you'd hope to be making a profit. Furthermore, you'd generally like to see...""}, {""date"": ""20230424123812"", ""headline"": ""4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates"", ""summary"": ""We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.""}, {""date"": ""20230424142606"", ""headline"": ""Oppenheimer Maintains AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230424145102"", ""headline"": ""Can Amgen (AMGN) Keep the Earnings Streak Alive in Q1?"", ""summary"": ""Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others is expected to have been partially offset by biosimilar/generic competition for mature drugs.""}, {""date"": ""20230424163600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.24% higher to $244.45 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230425020113"", ""headline"": ""Top Biotech Stocks For Q2 2023: First Gem Is BioNTech"", ""summary"": """"}, {""date"": ""20230425062643"", ""headline"": ""Is Amgen A Buy Ahead Of The Q1 Results?"", ""summary"": ""Amgen will publish its Q1 results in a couple of days, followed by an earnings call post-market hours. Click here to read a detailed analysis of AMGN stock.""}, {""date"": ""20230425123100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Bluebird Bio (BLUE) and InMode (INMD)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230425163600"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors despite daily gains"", ""summary"": ""Shares of Amgen Inc. inched 0.17% higher to $244.87 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230426010200"", ""headline"": ""Dow`s 182-point fall led by losses in Merck, Honeywell shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426025500"", ""headline"": ""Will Amgen`s streak of EPS beats continue in Q1?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426063746"", ""headline"": ""14 Best Income Stocks To Invest In"", ""summary"": ""In this article, we discuss 14 best income stocks to invest in. You can skip our detailed analysis of income stocks and the performance of dividend stocks over the years, and go directly to read 5 Best Income Stocks To Invest In. Income stocks are picking up steam this year because they offer a relatively [\u2026]""}, {""date"": ""20230426083200"", ""headline"": ""EU publishes proposed reforms for pharma industry"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426113500"", ""headline"": ""Will Humira competition impact AbbVie Q1 results?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426122600"", ""headline"": ""Democratic senators introduce bill to enhance CMS drug price negotiations"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230426130001"", ""headline"": ""These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar"", ""summary"": ""The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.""}, {""date"": ""20230426163600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 2.48% to $238.80 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230427003000"", ""headline"": ""GLOBAL BRIEFING: Samsung posts weakest profit in 14 years in Q1"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427011100"", ""headline"": ""Notable companies reporting after market close"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427023600"", ""headline"": ""Noteworthy Thursday Option Activity: AMGN, COOP, OXY"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427030100"", ""headline"": ""Amgen reports Q1 adjusted EPS $3.98, consensus $3.85"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427030400"", ""headline"": ""Amgen raises FY23 adjusted EPS view to $17.60-$18.70 from $17.40-$18.60"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427030800"", ""headline"": ""Amgen Non-GAAP EPS of $3.98 in-line, revenue of $6.1B misses by $140M"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427035400"", ""headline"": ""Amgen 2023 revenue, earnings outlook include consensus estimates"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427040500"", ""headline"": ""Mizuho Securities Sticks to Their Hold Rating for Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427054500"", ""headline"": ""Fly Intel: After-Hours Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427055800"", ""headline"": ""Lilly obesity therapy shows ~16% weight loss in Phase 3 trial"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427094523"", ""headline"": ""Revenue Headwinds Pull Amgen Into Neutral"", ""summary"": ""Amgen is a large biotechnology constituent of the Dow Jones Industrial Average index. Learn why AMGN is no longer a Buy.""}, {""date"": ""20230427143000"", ""headline"": ""Time To Sound The Warning Bells For AbbVie?"", ""summary"": ""AbbVie reported Q1 results that investors found underwhelming. Read more to know why I rate ABBV stock as a hold.""}, {""date"": ""20230427162300"", ""headline"": ""Amgen 1Q Net Income Surges Despite 2% Dip in Revenue"", ""summary"": ""By Denny Jacob Amgen Inc. net income surged in the latest quarter even as revenue declined slightly. The biotechnology company logged net income of $2.84...""}, {""date"": ""20230427162500"", ""headline"": ""Amgen: Q1 Earnings Snapshot"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427162700"", ""headline"": ""Amgen Raises 2023 Revenue, EPS Outlook"", ""summary"": ""By Denny Jacob Amgen Inc. on Thursday raised its 2023 outlook after volume grew in the latest quarter. The biotechnology company guided for revenue between...""}, {""date"": ""20230427171500"", ""headline"": ""Amgen sales drop due to lower Covid-19 manufacturing collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230427171938"", ""headline"": ""Stocks making the biggest moves after hours: Amazon, Intel, Snap, Pinterest and more"", ""summary"": ""These are the stocks posting the largest moves in extended trading.""}, {""date"": ""20230427200100"", ""headline"": ""AMGEN REPORTS FIRST QUARTER FINANCIAL RESULTS"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced financial results for the first quarter of 2023.""}, {""date"": ""20230427200221"", ""headline"": ""Amgen 1st quarter profit falls as costs rise, sales flatten"", ""summary"": ""Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.  Product sales by volume grew 14% from a year earlier, but was partially offset by a 5% decline in net selling prices due to unfavorable foreign exchange and sales deductions, such as rebates.  Amgen reported revenue of $6.1 billion for the quarter, down 2% from a year earlier, but in line with analysts' estimates of $6.13 billion, according to Refinitiv data.""}, {""date"": ""20230427205438"", ""headline"": ""UPDATE 1-Amgen 1st quarter profit falls as costs rise, sales flatten"", ""summary"": ""Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.  Product sales by volume grew 14% from a year earlier, but net selling prices fell 5%, while foreign exchange rates and other factors also limited sales revenue gains, Amgen said.  Amgen is seeing prescription trends return to prepandemic levels and \""demand for medicines is resilient despite current macroeconomic challenges,\"" Amgen Chief Executive Robert Bradway said on a conference call with investors.""}, {""date"": ""20230427212802"", ""headline"": ""Amgen Inc. (AMGN) Q1 2023 Earnings Call Transcript"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) Q1 2023 Earnings Conference Call April 27, 2023 4:30 PM ETCompany ParticipantsArvind Sood - Vice President of Investor RelationsBob Bradway - Chairman and...""}, {""date"": ""20230427213509"", ""headline"": ""Amgen (AMGN) Q1 Earnings Beat Estimates"", ""summary"": ""Amgen (AMGN) delivered earnings and revenue surprises of 3.65% and 0.66%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?""}, {""date"": ""20230427220023"", ""headline"": ""Amgen 1st quarter profit falls as costs rise, sales up 2%"", ""summary"": ""Amgen Inc on Thursday reported lower first-quarter profit as expenses rose and a 2% increase in sales of its own drugs was offset by lower revenue from its deal to manufacture COVID-19 antibody treatments for Eli Lilly and Co.""}, {""date"": ""20230428003700"", ""headline"": ""GLOBAL BRIEFING: BoJ leaves rates unchanged; Intel swings to loss"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428020600"", ""headline"": ""Catalyst watch: FOMC, Apple earnings, Kenvue IPO and jobs report are on tap"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428032600"", ""headline"": ""Goldman Sachs Reaffirms Their Buy Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428062000"", ""headline"": ""Analysts` Top Healthcare Picks: Amgen (AMGN), Dexcom (DXCM)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428064900"", ""headline"": ""Amgen price target lowered to $288 from $293 at Piper Sandler"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428073000"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Dexcom (DXCM) and Merck & Company (MRK)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428092600"", ""headline"": ""Video: Dow Movers: AMGN, INTC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230428140331"", ""headline"": ""Weight loss drug market is just beginning to take off, says Mizuho's Jared Holz"", ""summary"": ""Jared Holz, Mizuho healthcare equity strategist, joins 'The Exchange' to discuss new weight loss drugs coming to market, forecasts for market expansion in weight loss drugs, and key players in the weight loss drug sector.""}, {""date"": ""20230428145841"", ""headline"": ""Why Amgen Shares Are Trading Lower Today"", ""summary"": ""Amgen Inc (NASDAQ: AMGN) reported Q1 FY23 sales of $6.11 billion, down 2% Y/Y, resulting from lower revenue from COVID-19 manufacturing collaboration, partially offset by a 2% increase in product sales. The consensus estimate stood at $6.17 billion. Product sales growth was driven by 14% volume growth, partially offset by 5% lower net selling price, 3% unfavorable changes to estimated sales deductions, 2% lower inventory levels, and 2% negative impact from foreign exchange. Excluding the 2% nega""}, {""date"": ""20230428155203"", ""headline"": ""Amgen (AMGN) Q1 Earnings Beat Estimates, 2023 View Raised"", ""summary"": ""Amgen (AMGN) beats estimates for earnings but misses the same for sales. It raises its earnings and sales guidance for 2023.""}, {""date"": ""20230428163600"", ""headline"": ""Amgen Inc. stock falls Friday, underperforms market"", ""summary"": ""Shares of Amgen Inc. shed 0.25% to $239.74 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230428182506"", ""headline"": ""What To Expect After The Failed AbbVie Drug Sales"", ""summary"": ""AbbVie's revenue amounted to $12,225 million in the first three months of 2023, 9.7% less than the previous year. Find out my recent analysis of ABBV stock.""}, {""date"": ""20230429000245"", ""headline"": ""Piper Sandler Maintains AMGEN (AMGN) Overweight Recommendation"", ""summary"": """"}, {""date"": ""20230429120016"", ""headline"": ""Possible bearish signals as Amgen Inc. (NASDAQ:AMGN) insiders disposed of US$5.2m worth of stock"", ""summary"": ""Many Amgen Inc. ( NASDAQ:AMGN ) insiders ditched their stock over the past year, which may be of interest to the...""}, {""date"": ""20230430015306"", ""headline"": ""27 Largest Biotech Companies in the US"", ""summary"": ""In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US. The largest biotech companies in the US have a total market cap of $88 trillion. Latest Developments in [\u2026]""}]",{}
16,2023-04-30,233.75241088867188,2023-05-07,230.62258911132812,-0.01338947378315758,D2,"[{""date"": ""20230430015306"", ""headline"": ""27 Largest Biotech Companies in the US"", ""summary"": ""In this article, we take a look at 27 largest biotech companies in the US. You can skip our detailed analysis of the biotech industry and go directly to the 5 Largest Biotech Companies in the US. The largest biotech companies in the US have a total market cap of $88 trillion. Latest Developments in [\u2026]""}, {""date"": ""20230501040800"", ""headline"": ""Amgen price target lowered to $225 from $227 at Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501041500"", ""headline"": ""Amgen (AMGN) Gets a Sell from Barclays"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501061700"", ""headline"": ""Galera Therapeutics expands commercial leadership team"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501062200"", ""headline"": ""Coherus Biosciences initiated with a Buy at Truist"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501084700"", ""headline"": ""RBC Capital Keeps Their Hold Rating on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501092000"", ""headline"": ""Coherus spikes as Truist starts at Buy on biosimilar business"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501094500"", ""headline"": ""Robert W. Baird Remains a Sell on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501095600"", ""headline"": ""SVB Securities Remains a Hold on Amgen (AMGN)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230501163600"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.35% to $238.90 Monday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230501180326"", ""headline"": ""Barclays Maintains AMGEN (AMGN) Underweight Recommendation"", ""summary"": """"}, {""date"": ""20230501235308"", ""headline"": ""Healthcare And Facebook Help Propel My 25 Stock ~$424K Portfolio To New Highs In April"", ""summary"": ""My portfolio, built specifically for my retirement ~20 years from now, features growth, dividends and risk stocks for. See how it performed in April 2023.""}, {""date"": ""20230502011000"", ""headline"": ""Market Briefing For Tuesday, May 2 `23"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230502074700"", ""headline"": ""Upcoming Dividend Run For AMGN?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230502134500"", ""headline"": ""2 Incredibly Cheap Dividend Stocks to Buy in May"", ""summary"": ""While the impact of an economic downturn on stocks is hard to predict, high-quality dividend stocks have a proven track record of delivering above market gains during turbulent periods.  Here are two dividend-paying pharmaceutical stocks that ought to hold up well in a recessionary environment, are proven passive income vehicles, and trade at extremely attractive valuations.  Amgen (NASDAQ: AMGN) is a global biotechnology company.""}, {""date"": ""20230502163600"", ""headline"": ""Amgen Inc. stock falls Tuesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 1.23% to $235.97 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230502223456"", ""headline"": ""Amgen sues Novartis to block generic osteoporosis, bone cancer drugs"", ""summary"": ""Amgen Inc sued Novartis AG's Sandoz in New Jersey federal court Monday, accusing Sandoz's proposed versions of its multibillion-dollar bone-strengthening drugs Prolia and Xgeva of infringing several patents.""}, {""date"": ""20230503021000"", ""headline"": ""Walgreens Boots, Amgen share losses lead Dow`s 85-point fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230503060000"", ""headline"": ""Amgen price target raised to $214 from $208 at Mizuho"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230503150025"", ""headline"": ""Amgen vs. Sandoz: Legal Battle Erupts Over Bone-Strengthening Drug Patents"", ""summary"": ""Amgen Inc (NASDAQ: AMGN) has reportedly sued Novartis AG's (NYSE: NVS) Generic arm Sandoz on proposed versions of its bone-strengthening drugs Prolia and Xgeva containing denosumab, infringing several patents. Amgen said the proposed biosimilars infringe 21 patents covering Prolia and Xgeva. Also Read: Amgen Faces Lawsuit For Hiding Its Stupendous Tax Bill Of $10B. Prolia is indicated for a high risk of bone fracture in certain settings, for example, osteoporosis. XGEVA is prescribed to prevent""}, {""date"": ""20230503150900"", ""headline"": ""Walgreens Boots, Amgen share losses lead Dow's 85-point fall"", ""summary"": ""Dragged down by declines for shares of Walgreens Boots and Amgen, the Dow Jones Industrial Average is falling Wednesday afternoon. The Dow was most recently...""}, {""date"": ""20230503163600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. shed 2.82% to $229.31 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230503200000"", ""headline"": ""AMGEN TO PRESENT AT THE 2023 BANK OF AMERICA MERRILL LYNCH GLOBAL HEALTHCARE CONFERENCE"", ""summary"": ""Amgen (NASDAQ:AMGN) will present at the 2023 Bank of America Merrill Lynch Global Healthcare Conference at 11:00 a.m. ET on Tuesday, May 9, 2023. David M. Reese, M.D., executive vice president of Research and Development and Peter H. Griffith, executive vice president and chief financial officer at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}, {""date"": ""20230503205231"", ""headline"": ""Dow Jones Today: Index Falls Following Rate Hike"", ""summary"": ""The Dow dropped 250 points with Walgreens taking the index lower after rival CVS cut its profit outlook.""}, {""date"": ""20230503222710"", ""headline"": ""Why Amgen Stock Was Sickly Today"", ""summary"": ""What happened Investors are often encouraged when one of their companies bulks up by acquiring a peer. But that sentiment can turn sour if the takeover target stumbles. This was the impetus behind Amgen's (NASDAQ: AMGN) nearly 3% decline on the stock market Wednesday.""}, {""date"": ""20230504013000"", ""headline"": ""Weight-Loss Drugs Will Be Blockbusters. Here\u2019s the Stock to Buy."", ""summary"": ""Everyone is talking about Eli Lilly\u2019s Mounjaro and Novo Nordisk\u2019s Ozempic. Now, the drugs are poised to go from conversation starters to profit makers.""}, {""date"": ""20230504133847"", ""headline"": ""Assertio Holdings: A Little More Risk, A Lot Higher Reward"", ""summary"": ""Assertio acquired a future blockbuster which may likely generate sales by itself are more than half the current market cap. Read why ASRT stock is a strong buy.""}, {""date"": ""20230504163600"", ""headline"": ""Amgen Inc. stock rises Thursday, outperforms market"", ""summary"": ""Shares of Amgen Inc. rose 1.13% to $231.89 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230504220133"", ""headline"": ""7 Blue-Chip Stocks to Buy in May 2023"", ""summary"": ""While large-capitalization enterprises don\u2019t offer much excitement, current circumstances may call for the best blue-chip stocks to buy. Frankly, it\u2019s getting a little bit toasty on Wall Street, which is why stability may come at a premium. Naturally, the failure of First Republic \u2013 the third such collapse of a banking enterprise this year \u2013 generated plenty of jitters. Despite JPMorgan Chase (NYSE:JPM) CEO Jamie Dimon\u2019s encouraging words that the FRC takeover averted a crisis, circumstances sti""}, {""date"": ""20230505045315"", ""headline"": ""High Yield Stock Watchlist: May 2023"", ""summary"": ""The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Click here for a detailed analysis.""}, {""date"": ""20230505134500"", ""headline"": ""2 Magnificent Dividend Stocks to Buy Before the Next Recession"", ""summary"": ""Let's look at two great dividend stocks to consider buying before the economy worsens: Gilead Sciences (NASDAQ: GILD) and Amgen (NASDAQ: AMGN).  Gilead Sciences is a biotech company with a particular focus on developing HIV medicines.  It has helped Gilead Sciences' revenue stay afloat as the company failed to earn approval for important candidates.""}, {""date"": ""20230505163600"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. rose 2.00% to $236.53 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230506115500"", ""headline"": ""2 Best Biotech Stocks to Buy Right Now"", ""summary"": ""Buying pharmaceutical companies with all-around drug portfolios and pipelines is the key to success as an investor.""}]",{}
17,2023-05-07,230.62258911132812,2023-05-14,227.13198852539062,-0.015135553717387507,D2,"[{""date"": ""20230508012600"", ""headline"": ""Amgen, Entera end research collaboration"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508052836"", ""headline"": ""DICE Therapeutics: Worth A Roll At The Right Price"", ""summary"": ""DICE Therapeutics recently posted encouraging Phase 1c data from its lead candidate, psoriasis therapy DC-806. Check out my recommendation on DICE stock.""}, {""date"": ""20230508080700"", ""headline"": ""Amgen investors given opportunity to lead securities fraud class action"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508090000"", ""headline"": ""Amgen highlights benefit of Prolia over Fosamax in fracture risk"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508091100"", ""headline"": ""Amgen osteoporosis drug Prolia outperforms commonly used therapy"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508091200"", ""headline"": ""Walgreens Boots, Amgen share losses lead Dow`s 84-point fall"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508101100"", ""headline"": ""Walgreens Boots, Amgen share losses lead Dow's 84-point fall"", ""summary"": ""The Dow Jones Industrial Average is down Monday morning with shares of Walgreens Boots and Amgen seeing the biggest declines for the blue-chip average....""}, {""date"": ""20230508105400"", ""headline"": ""Video: Dow Movers: AMGN, DIS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230508130000"", ""headline"": ""NEW DATA FROM AMGEN'S PROLIA\u00ae (DENOSUMAB) DEMONSTRATES SIGNIFICANT REDUCTION IN OSTEOPOROTIC FRACTURE RISK COMPARED TO ALENDRONATE"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new data from a real-world study of nearly half of a million postmenopausal women with osteoporosis in the U.S. medicare program showing Prolia\u00ae (denosumab) injection reduced fracture risk in patients versus oral alendronate, a frequently prescribed bisphosphonate treatment. Treatment with Prolia was also associated with greater reductions in fracture risk over time. The data were presented during an oral presentation at the World Congress on Osteoporosis, Ost""}, {""date"": ""20230508133243"", ""headline"": ""WTV: A Shareholder Yield ETF With Great Valuation"", ""summary"": ""WisdomTree U.S. Value Fund ETF is an actively managed fund focused on dividends, buybacks and quality. Click for my review of the WTV ETF.""}, {""date"": ""20230508163600"", ""headline"": ""Amgen Inc. stock underperforms Monday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 0.81% to $234.62 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230509080400"", ""headline"": ""Amgen and TScan Therapeutics partner for Crohn`s Disease target identification"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509080500"", ""headline"": ""Amgen, TScan Therapeutics announce collaboration to identify targets in Crohn`s"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509081600"", ""headline"": ""TScan Therapeutics stock soars after Amgen collaboration on Crohn`s disease treatment that could bring in more than $500 million"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509090000"", ""headline"": ""AMGEN AND TSCAN THERAPEUTICS ANNOUNCE COLLABORATION TO IDENTIFY NOVEL TARGETS IN CROHN'S DISEASE"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509091200"", ""headline"": ""TScan jumps 102% after deal with Amgen for Crohn`s disease"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509091500"", ""headline"": ""TScan Therapeutics stock soars after Amgen collaboration on Crohn\u2019s disease treatment that could bring in more than $500 million"", ""summary"": ""Shares of TScan Therapeutics Inc. powered up 43.1% in premarket trading Tuesday, after the biopharmaceutical company announced a collaboration with Amgen...""}, {""date"": ""20230509091800"", ""headline"": ""Amgen, TScan Therapeutics Set Crohn's Disease Collaboration"", ""summary"": ""By Colin Kellaher Amgen on Tuesday said it has signed onto a multi-year collaboration with clinical-stage biopharmaceutical company TScan Therapeutics...""}, {""date"": ""20230509093800"", ""headline"": ""TScan Therapeutics Shares Take Flight on Amgen Pact >TCRX"", ""summary"": ""By Colin Kellaher TScan Therapeutics shares surged on Tuesday after the clinical-stage biopharmaceutical company said it entered a collaboration potentially...""}, {""date"": ""20230509100600"", ""headline"": ""TScan Therapeutics More than Doubles Following Deal with Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509104900"", ""headline"": ""O`Keefe Stevens Advisory Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509113000"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Axsome Therapeutics (AXSM) and Shockwave Medical (SWAV)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230509130000"", ""headline"": ""Amgen and TScan Therapeutics Announce Collaboration to Identify Novel Targets in Crohn\u2019s Disease"", ""summary"": ""Collaboration Brings Together TScan\u2019s Proprietary Target Discovery Platform and Amgen\u2019s Inflammation Therapeutic Expertise and Research Capabilities TScan to Receive $30 Million Upfront With Potential Development and Commercial Milestone Payments of Over $500 Million THOUSAND OAKS, Calif. and WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Amgen (NASDAQ:AMGN) and TScan Therapeutics, Inc. (NASDAQ:TCRX), today announced a multi-year collaboration that will use TScan\u2019s proprietary target discovery""}, {""date"": ""20230509140012"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Shares Could Be 42% Below Their Intrinsic Value Estimate"", ""summary"": ""Key Insights Amgen's estimated fair value is US$405 based on 2 Stage Free Cash Flow to Equity Amgen's US$235 share...""}, {""date"": ""20230509150358"", ""headline"": ""RBC Capital Reiterates AMGEN (AMGN) Sector Perform Recommendation"", ""summary"": """"}, {""date"": ""20230509163600"", ""headline"": ""Amgen Inc. stock outperforms competitors despite losses on the day"", ""summary"": ""Shares of Amgen Inc. sank 0.08% to $234.43 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230509172920"", ""headline"": ""Why Are TScan Therapeutics Shares Are Shooting Higher Today"", ""summary"": ""Amgen Inc (NASDAQ: AMGN) and TScan Therapeutics Inc (NASDAQ: TCRX) announced a multi-year collaboration to use TScan's proprietary target discovery platform, TargetScan, to identify the antigens recognized by T cells in patients with Crohn's disease. Under the terms of the agreement, TScan will receive a $30 million upfront payment and is eligible to earn over $500 million in milestones and tiered single-digit royalty payments. Amgen will evaluate a variety of modalities to create therapeutics b""}, {""date"": ""20230509200959"", ""headline"": ""15 Biggest Immunotherapy Companies in the World"", ""summary"": ""In this article, we will take a look at the 15 biggest immunotherapy companies in the world. If you want to see more companies in this selection, go to the 5 Biggest Immunotherapy Companies in the World. The immunotherapy industry is a rapidly growing field that is focused on developing treatments that harness the power [\u2026]""}, {""date"": ""20230509234500"", ""headline"": ""O'Keefe Stevens Advisory Q1 2023 Update"", ""summary"": ""O'Keefe Stevens Advisory released its Q1 2023 update recently. Click here to read the full fund letter. ""}, {""date"": ""20230510085200"", ""headline"": ""Dow`s 100-point fall led by losses for shares of Travelers, Chevron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230510163600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slipped 0.14% to $234.11 Wednesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230510191203"", ""headline"": ""May Dogs Of The Dow: Buy 2, Watch 4"", ""summary"": ""The Dow adds a stock if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors. Click for our lists.""}, {""date"": ""20230510194153"", ""headline"": ""Novartis CEO criticizes US, EU efforts to curb drug company power"", ""summary"": ""Novartis CEO pushes back against government attempts to direct pharma RD""}, {""date"": ""20230511020100"", ""headline"": ""Walt Disney, Intel share losses contribute to Dow`s 234-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230511130741"", ""headline"": ""GOP law cut Big Pharma tax rates by 40%, Senate report says"", ""summary"": ""Senate Finance Committee Democrats said the Republican bill resulted in billion of dollars in tax savings for pharmaceutical companies.\u00a0""}, {""date"": ""20230511163600"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 0.78% to $232.29 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230512025800"", ""headline"": ""Horizon Therapeutics ticks higher amid report FTC meeting unrelated to Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230512100832"", ""headline"": ""Amgen Inc. (NASDAQ:AMGN) Pays A US$2.13 Dividend In Just Four Days"", ""summary"": ""Regular readers will know that we love our dividends at Simply Wall St, which is why it's exciting to see Amgen Inc...""}, {""date"": ""20230512163600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.28% higher to $232.95 Friday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230513090000"", ""headline"": ""How To Invest $100,000 Today: The Near-Perfect Portfolio Strategy"", ""summary"": ""With the economy going through boom and bust cycles more frequently, extreme market ups and downs are inevitable. Click here for more.""}, {""date"": ""20230513190011"", ""headline"": ""Amgen Inc. (AMGN) Presents at BofA Securities 2023 Health Care Conference (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) BofA Securities 2023 Health Care Conference May 9, 2023 11:00 AM ETCompany ParticipantsPeter Griffith - CFODave Reese - EVP, R&DConference Call...""}, {""date"": ""20230513233317"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of May 14"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Read more to see the companies with upcoming ex-dividend dates.""}]",{}
18,2023-05-14,227.13198852539062,2023-05-21,219.89537048339844,-0.03186084923120913,D4,"[{""date"": ""20230515062907"", ""headline"": ""BridgeBio Pharma: A Lot Of Paths To Potential Success"", ""summary"": ""BridgeBio has had some positive recent trial developments and executed a needed capital raise in March. Find out a full investment analysis of BBIO stock.""}, {""date"": ""20230515070400"", ""headline"": ""FTC looks to blow Horizon Therapeutics acquisition by Amgen, Capitol Forum says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515072300"", ""headline"": ""FTC looks to block Horizon Therapeutics deal with Amgen, Capitol Forum says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515090200"", ""headline"": ""Ex-Dividend Reminder: Amgen, Select Medical Holdings and Laboratory Corporation of America Holdings"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230515163600"", ""headline"": ""Amgen Inc. stock rises Monday, still underperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.25% higher to $233.53 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500...""}, {""date"": ""20230515195401"", ""headline"": ""Lightning Round: 'I don't like companies that pick fights with the SEC', says Jim Cramer on Coinbase"", ""summary"": ""'Mad Money' host Jim Cramer weighs in on stocks including: Chewy, Enterprise Products, Coinbase, Triple Flag Precious Metals, Amgen, GSK, IONQ, Southern Co., and Snowflake.""}, {""date"": ""20230515195803"", ""headline"": ""Cramer's Lightning Round: I am not a believer in Coinbase"", ""summary"": ""\""Mad Money\"" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.""}, {""date"": ""20230515212800"", ""headline"": ""Horizon shares sink on report that FTC will sue to block takeover by Amgen"", ""summary"": ""Shares of Horizon Therapeutics Inc. plunged 15% in extended trading Monday after Bloomberg News reported the FTC is expected to file a lawsuit to block Amgen...""}, {""date"": ""20230516010800"", ""headline"": ""FTC suit against Horizon deal may have chilling effect on biotech M&A"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516011900"", ""headline"": ""FTC Surprise Challenge Of Amgen`s Acquisition Of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516013527"", ""headline"": ""UPDATE 2-FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - source"", ""summary"": ""The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc's $27.8 billion deal to buy Horizon Therapeutics PLC, a person familiar with the matter told Reuters.  Amgen struck a deal last year to buy Horizon to strengthen its rare diseases drugs portfolio.  Amgen said on Monday it wasn't aware of any decision made by the agency.""}, {""date"": ""20230516013700"", ""headline"": ""Pfizer bond offering to fund Seagen deal said to among largest on record"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516014900"", ""headline"": ""Pfizer bond offering to fund Seagen deal said to be among largest on record"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516021000"", ""headline"": ""Dow falls, Nasdaq edges up with U.S. debt-ceiling talks in focus"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516021129"", ""headline"": ""FTC to block Amgen's $27.8 billion deal for Horizon Therapeutics - source"", ""summary"": ""The U.S. Federal Trade Commission is expected to file a lawsuit as early as Tuesday to block Amgen Inc's $27.8 billion deal to buy Horizon Therapeutics PLC, a person familiar with the matter told Reuters.""}, {""date"": ""20230516042400"", ""headline"": ""FTC will sue to block Horizon Therapeutics takeover by Amgen, Bloomberg says"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516044525"", ""headline"": ""Amgen\u2019s $28 Billion Horizon Buy Will Be Challenged by FTC"", ""summary"": ""(Bloomberg) -- Amgen Inc.\u2019s $27.8 billion deal to buy Horizon Therapeutics Plc, the largest in the biotechnology company\u2019s history, will be challenged by federal regulators who argue the tie-up would hamper innovation and slow the pace of drug development, according to a person familiar with the matter.Most Read from BloombergTurkey Latest: Erdogan Says Unclear If Vote Will Go to RunoffMichael Burry Doubles Alibaba Stake in Big Bet on China TechTurkey Set for Runoff as Erdogan Falls Just Short o""}, {""date"": ""20230516052500"", ""headline"": ""Capital One stock rallies and Home Depot shares dips, and other companies on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516053200"", ""headline"": ""Seagen, impacted by FTC Amgen/Horizon suit, closes down 6%"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516054100"", ""headline"": ""Amgen-Horizon Deal: A Major Roadblock in Sight"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516055900"", ""headline"": ""Horizon Shares Slide Premarket on Report That FTC to Fight Amgen Deal"", ""summary"": ""By Colin Kellaher Horizon Therapeutics tumbled in premarket trading Tuesday following a published report that U.S. regulators will move to block the $27.8...""}, {""date"": ""20230516060900"", ""headline"": ""Home Depot`s stock selloff would cut nearly 80 points off the Dow`s price"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516061800"", ""headline"": ""Capital One stock rallies and Home Depot shares dip, and other companies on the move"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516065400"", ""headline"": ""Jefferies thinks Amgen-Horizon deal still gets done after `speed bump`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516070700"", ""headline"": ""Home Depot\u2019s stock selloff would cut nearly 80 points off the Dow\u2019s price"", ""summary"": ""Shares of Home Depot Inc. took a 4.0% dive, to pace the Dow Jones Industrial Average\u2019s premarket decliners, after the home improvement retailer missed fiscal...""}, {""date"": ""20230516072159"", ""headline"": ""Wall Street Breakfast Podcast: 13F Filings: Berkshire Takes New Stakes In COF, DEO"", ""summary"": ""Warren Buffett's Berkshire takes new stakes in COF, Diageo, exits RH. Daniel Loeb's Third Point amasses new stakes in Alphabet, Micron, AMD, Alibaba. Rumble buys Callin.""}, {""date"": ""20230516073100"", ""headline"": ""Analysts Offer Insights on Healthcare Companies: Amgen (AMGN), Compugen (CGEN) and Eli Lilly & Co (LLY)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516073900"", ""headline"": ""What You Missed On Wall Street On Tuesday"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516074300"", ""headline"": ""Seagen, Prometheus Biosciences fall amid news of FTC planned block of Horizon/Amgen deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516075400"", ""headline"": ""AstraZeneca to exit leading U.S. drug industry group PhRMA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516075900"", ""headline"": ""Fly Intel: Pre-market Movers"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516083700"", ""headline"": ""HZNP Stock Alert: Why Is Horizon Therapeutics Plunging Today"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516094000"", ""headline"": ""FTC files suit to block Amgen acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516095700"", ""headline"": ""FTC sues to block Amgen, Horizon Therapeutics deal on monopoly concerns"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516103400"", ""headline"": ""Amgen remains committed to closing Horizon Therapeutics deal by mid-December"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516103400"", ""headline"": ""Amgen `disappointed` in FTC`s decision to block Horizon Therapeutics deal"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516103400"", ""headline"": ""Amgen responds to FTC action on proposed acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516103500"", ""headline"": ""Amgen: Horizon Therapeutics deal poses `no legitimate competitive issues`"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516105000"", ""headline"": ""Horizon Therapeutics responds to FTC`s action to block acquisition by Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516105959"", ""headline"": ""FTC sues to block Amgen acquisition of Horizon Therapeutics"", ""summary"": ""The Federal Trade Commission on Tuesday said it has sued to block Amgen's $27.8 billion acquisition of Horizon Therapeutics. CNBC's David Faber reports.""}, {""date"": ""20230516110500"", ""headline"": ""What You Missed On Wall Street This Morning"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516111100"", ""headline"": ""FTC sues to block Amgen`s acquisition of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516112200"", ""headline"": ""Tracking George Soros`s Portfolio - Q1 2023 Update"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516113100"", ""headline"": ""AMGEN RESPONDS TO FTC ACTION RE: PROPOSED ACQUISITION OF HORIZON THERAPEUTICS"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516115400"", ""headline"": ""Prometheus, Seagen slip after FTC sues to block Horizon acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516115600"", ""headline"": ""Monopoly concerns push FTC to sue to block Amgen's more than $26B deal for Horizon"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516120200"", ""headline"": ""Hot Stocks: SE and IQ slip after earnings; HZNP down on FTC lawsuit; VOD fall on job cuts; AMD and VKTX gain"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516123500"", ""headline"": ""Seagen likely to stay `distanced` from deal price after FTC action, says Stifel"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516123826"", ""headline"": ""Stocks making the biggest moves midday: Horizon Therapeutics, Capital One, RH, Home Depot and more "", ""summary"": ""These are the stocks posting the largest moves midday.""}, {""date"": ""20230516125800"", ""headline"": ""Trade commission fights Amgen's $28B purchase of Horizon Therapeutics"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516140556"", ""headline"": ""US STOCKS-Wall St falls as Home Depot, retail sales data weigh "", ""summary"": ""U.S. stocks fell on Tuesday after a dour forecast from Home Depot and April retail sales data pointed to consumers feeling the pinch from rising prices and interest rates, ahead of crucial debt limit talks.""}, {""date"": ""20230516140620"", ""headline"": ""Wall St falls as Home Depot, retail sales data weigh"", ""summary"": ""U.S. stocks fell on Tuesday after a dour forecast from Home Depot and April retail sales data pointed to consumers feeling the pinch from rising prices and interest rates, ahead of crucial debt limit talks.""}, {""date"": ""20230516141631"", ""headline"": ""FTC Surprise Challenge Of Amgen's Acquisition Of Horizon Therapeutics"", ""summary"": ""Amgen is facing a suit from the FTC to block its acquisition of Horizon Therapeutics. Check out my key takeaways for AMGN and HZNP investors.""}, {""date"": ""20230516142956"", ""headline"": ""Jefferies' Michael Yee expects Amgen's Horizon Therapeutics deal will go through despite FTC block"", ""summary"": ""Michael Yee, Jefferies managing director, joins 'Power Lunch' to discuss the FTC's move to block Amgen's $27.8 billion deal for Horizon Therapeutics.""}, {""date"": ""20230516143936"", ""headline"": ""FTC Commissioners yet to meet on Amgen-Horizon deal - CNBC"", ""summary"": ""Commissioners at the U.S. Federal Trade Commission (FTC) have not yet met to discuss Amgen's acquisition of Horizon Therapeutics, CNBC reported on Tuesday.""}, {""date"": ""20230516145219"", ""headline"": ""FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics -statement"", ""summary"": ""The U.S. Federal Trade Commission said on Tuesday that it would sue to stop Amgen Inc's $27.8 billion deal to buy Horizon Therapeutics Plc .""}, {""date"": ""20230516150000"", ""headline"": ""US sues to block USD28 billion Amgen biopharma acquisition"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230516155537"", ""headline"": ""Factbox-Amgen-Horizon deal joins mega mergers facing regulatory heat"", ""summary"": ""A U.S. antitrust regulator said on Tuesday it will sue to stop Amgen's $27.8 billion deal for Horizon Therapeutics Plc, as it would give Amgen \""monopoly positions\"" in treatments for thyroid eye disease and chronic refractory gout.""}, {""date"": ""20230516162125"", ""headline"": ""US FTC sues to block Amgen's $27.8 billion deal for Horizon Therapeutics"", ""summary"": ""The U.S. Federal Trade Commission said on Tuesday it would sue to stop Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal.""}, {""date"": ""20230516163600"", ""headline"": ""Why These 2 Large-Cap Stocks Dropped 10%-Plus on Tuesday"", ""summary"": ""Although the Nasdaq Composite managed to post modest gains, the Dow Jones Industrial Average and S&P 500 were both lower.  Sea Limited (NYSE: SE) raised some concerns about the strength of consumers in the Asia-Pacific region, while shareholders in Horizon Therapeutics (NASDAQ: HZNP) had to deal with a threat that could bring hopes for a lucrative acquisition to a grinding halt.  Shares of Sea Limited dropped 15% on Tuesday morning following the release of the Southeast Asian e-commerce and video game specialist's latest financial results.""}, {""date"": ""20230516163700"", ""headline"": ""Amgen Inc. stock underperforms Tuesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 2.42% to $227.88 Tuesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230516164100"", ""headline"": ""FTC Sues to Block Amgen\u2019s $27.8 Billion Acquisition of Horizon Therapeutics"", ""summary"": ""Amgen reached an agreement to buy Horizon in December, and at the time said it expected the deal to be completed in the first half of 2023.""}, {""date"": ""20230516165002"", ""headline"": ""US STOCKS-Dow, S&P 500 fall as Home Depot, retail sales data weigh"", ""summary"": ""The Dow and the S&P 500 fell on Tuesday after a dour forecast from Home Depot and April retail sales data pointed to consumers feeling the pinch from rising prices and interest rates, ahead of crucial debt limit talks.""}, {""date"": ""20230516174906"", ""headline"": ""FTC Sues to Block Amgen\u2019s Acquisition of Horizon Therapeutics"", ""summary"": ""The Federal Trade Commission is suing to block Amgen Inc.'s $28 billion acquisition of Horizon Therapeutics to prevent a monopoly in the market for d.rugs that treat critical ailments""}, {""date"": ""20230516184014"", ""headline"": ""Horizon Therapeutics Stock Plunges as FTC Plans to Block Amgen Deal"", ""summary"": ""Amgen\u2019s nearly $28 billion cash deal to buy Horizon Therapeutics is in jeopardy.  Horizon shares were recently down around 15% on the news that the Federal Trade Commission is planning a lawsuit to [block the deal](https://www.wsj.com/articles/ftc-poised-to-block-amgens-27-8-billion-deal-for-horizon-therapeutics-a9c1b499).  Horizon closed Monday at $112.25 a share, which is a less than 4% discount to the planned acquisition price.""}, {""date"": ""20230516184701"", ""headline"": ""US STOCKS-S&P 500, Dow fall, dragged by Home Depot outlook, US retail sales"", ""summary"": ""The Dow and the S&P 500 retreated on Tuesday after a disappointing forecast from Home Depot and U.S. retail sales data for April pointed to softer consumer spending, while uncertainty about interest rates and debt limit negotiations weighed on sentiment.""}, {""date"": ""20230516191607"", ""headline"": ""FTC May Reportedly Block Amgen's (AMGN) $28B Horizon Buyout"", ""summary"": ""Unconfirmed reports suggest that the FTC may challenge the $28-billion buyout of Horizon Therapeutics (HZNP) by Amgen.""}, {""date"": ""20230516193317"", ""headline"": ""UPDATE 5-US FTC sues to block Amgen's $27.8 bln deal for Horizon Therapeutics"", ""summary"": ""The U.S. Federal Trade Commission said on Tuesday it has filed a lawsuit to stop Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics Plc in a rare move to block a large pharmaceutical deal.  The FTC said it opposed the deal because of concern that Amgen would leverage its big selling drugs to pressure insurance companies and pharmacy benefit managers to give favorable terms for Horizon's two key products - the fast-growing thyroid eye disease treatment Tepezza and gout drug Krystexxa.  The FTC decision to stop this acquisition marks a change.""}, {""date"": ""20230516193348"", ""headline"": ""FTC sues to block Amgen's $27.8 billion deal to acquire Horizon Therapeutics"", ""summary"": ""Yahoo Finance healthcare reporter Anjalee Khemlani joins the Live Show to discuss details surrounding the FTC suing biopharmaceutical giant Amgen Inc and its plan to block Amgen's $27.8 billion deal to acquire Horizon Therapeutics.""}, {""date"": ""20230516193808"", ""headline"": ""FTC sues to stop Amgen\u2019s $27.8B deal for Horizon Therapeutics"", ""summary"": ""The FTC said in its complaint that Amgen would be able to leverage its position with insurance companies and pharmacy benefit managers wanting access to its blockbuster drugs.""}, {""date"": ""20230516200040"", ""headline"": ""US STOCKS-Wall Street declines after Home Depot outlook, US retail sales"", ""summary"": ""U.S. stock indexes closed lower on Tuesday after a disappointing forecast from Home Depot and U.S. retail sales data for April pointed to softer consumer spending, while uncertainty about interest rates and debt limit negotiations weighed on sentiment.""}, {""date"": ""20230516201636"", ""headline"": ""Horizon Tumbles \u2014 Taking Seagen, Prometheus With It \u2014 As FTC Blocks Amgen Takeover"", ""summary"": ""The FTC plans to block Amgen's takeover of Horizon. The move reverberated across biotechs, with an HZNP stock crash leading the way.""}, {""date"": ""20230516201837"", ""headline"": ""CORRECTED-US STOCKS-Wall Street closes lower after Home Depot outlook, US retail sales"", ""summary"": ""U.S. stock indexes closed lower on Tuesday after a disappointing forecast from Home Depot and U.S. retail sales data for April pointed to softer consumer spending, while uncertainty about interest rates and debt limit negotiations weighed on sentiment.  Home Depot declined 2.15% as one of the biggest drag on both the Dow Industrials and S&P 500 after the home improvement retailer cut its annual sales forecast and projected a steeper-than-expected decline in profit.""}, {""date"": ""20230516202153"", ""headline"": ""Lowe's, Horizon Therapeutics, AMD: Stocks moving ahead of the close"", ""summary"": ""The Yahoo Finance Live team discusses stocks to watch at the closing bell, including Lowe's, Horizon Therapeutics, AMD, and Nvidia.""}, {""date"": ""20230516204851"", ""headline"": ""Markets Fall on Home Depot Warning, Debt Talks"", ""summary"": ""U.S. equities fell on Tuesday, May 16, 2023 as Home Depot\u2019s revenue warning raised concerns about economic growth, and as President Biden met with congressional leaders on the debt ceiling to avoid a government default.""}, {""date"": ""20230516210440"", ""headline"": ""Dow Jones Today: Index Falls on Retail Sales Slump"", ""summary"": ""The Dow Jones Industrial Average fell 1%, or 336 points, on a day of disappointing earnings and macroeconomic reports. Nike lost the most, while Microsoft led a small pack of gainers.""}, {""date"": ""20230516210719"", ""headline"": ""Pfizer Sells $31 Billion of Bonds in Fourth-Largest Deal Ever"", ""summary"": ""(Bloomberg) -- Pfizer Inc. sold $31 billion of debt in the fourth-largest US bond sale ever, according to a person with knowledge of the matter.Most Read from BloombergA 32-Year-Old Nears Billionaire Status by Using AI to Broker Japan MergersHere\u2019s How Much Wealth You Need to Join the Richest 1% GloballyDebt-Limit Talks to Intensify as Biden Set to Depart for JapanGoldman Banker Wins Promotion, Then Leaves for Rival Two Weeks LaterGoogle Billionaire Sergey Brin Gifts $600 Million in Surging Shar""}, {""date"": ""20230516210838"", ""headline"": ""Home Depot, FTC blocks Amgen deal, Comcast's Hulu stake: Tuesday's top headlines"", ""summary"": ""The Yahoo Finance Live team breaks down Tuesday's biggest stories, including Home Depot earnings report, the FTC suing to block Amgen's deal to buy Horizon Therapeutics, and Comcast's talks to sell its Hulu stake to Disney.""}, {""date"": ""20230516211556"", ""headline"": ""FTC Sues Over Amgen\u2019s $28 Billion Horizon Therapeutics Deal"", ""summary"": ""(Bloomberg) -- The Federal Trade Commission sued to block Amgen Inc.\u2019s $27.8 billion deal to buy Horizon Therapeutics Plc Tuesday, arguing the tie-up would stifle competition for the development of treatments for serious illnesses. Most Read from BloombergA 32-Year-Old Nears Billionaire Status by Using AI to Broker Japan MergersHere\u2019s How Much Wealth You Need to Join the Richest 1% GloballyDebt-Limit Talks to Intensify as Biden Set to Depart for JapanGoldman Banker Wins Promotion, Then Leaves fo""}, {""date"": ""20230516212400"", ""headline"": ""FTC Moves to Block Amgen\u2019s $27.8 Billion Deal for Horizon Therapeutics"", ""summary"": ""The FTC hasn\u2019t often challenged mergers involving drugmakers, but under Chair Lina Khan it has taken a stricter stance on deals.""}, {""date"": ""20230517000006"", ""headline"": ""The FTC Wants to Block the $28 Billion Amgen-Horizon Therapeutics Deal"", ""summary"": ""Big Pharma needs an antitrust antidote. The Federal Trade Commission and its hard-nosed chair Lina Khan have struck again, this time filing a...""}, {""date"": ""20230517001941"", ""headline"": ""Tracking George Soros's Portfolio - Q1 2023 Update"", ""summary"": ""Soros' 13F portfolio value decreased from $7.26B to $6.49B this quarter. Click here to see an update on the portfolio's trades for Q1 2023.""}, {""date"": ""20230517003346"", ""headline"": ""Wall Street closes lower after Home Depot outlook, US retail sales"", ""summary"": ""U.S. stock indexes closed lower on Tuesday after a disappointing forecast from Home Depot and U.S. retail sales data for April pointed to softer consumer spending, while uncertainty about interest rates and debt limit negotiations weighed on sentiment.""}, {""date"": ""20230517020600"", ""headline"": ""Amgen-Horizon Deal Stumbles on FTC`s Lawsuit"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517021500"", ""headline"": ""U.S. stocks are falling after Home Depot report, weak retail sales"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517021500"", ""headline"": ""Midday movers: Home Depot, Capital One Financial, Tesla and more"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517025500"", ""headline"": ""Regeneron CEO backs regulators attempt to block Amgen deal, FT reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517040100"", ""headline"": ""Regeneron boss backs attempt to block $28bn Amgen acquisition"", ""summary"": ""The Regeneron chief executive has backed an attempt by US regulators to block Amgen\u2019s $28bn acquisition of Horizon Therapeutics as he accused some pharmaceutical companies of abusing their market power to prevent competition.  Leonard Schleifer said he supported the US Federal Trade Commission\u2019s decision to tackle a \u201cnew area\u201d after the agency made its first attempt to block a pharma deal in over a decade by filing a novel lawsuit against the Amgen transaction.  Drugmakers pay rebates to ensure their treatment is placed on the lists of drugs covered by insurance companies.""}, {""date"": ""20230517041031"", ""headline"": ""US sues to block drug merger"", ""summary"": ""This is an audio transcript of the FT News Briefing podcast episode: \u2018US sues to block drug merger\u2019Marc Filippino Good morning from the Financial Times. Today is Wednesday, May 17th, and this is your FT News Briefing.""}, {""date"": ""20230517062100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN) and ReShape Lifesciences (RSLS)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517073038"", ""headline"": ""Wall Street Breakfast: Retail On The Radar"", ""summary"": ""Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify.""}, {""date"": ""20230517090600"", ""headline"": ""Is This Dow Jones Stock a Buy for Income Investors?"", ""summary"": ""Replacing Pfizer (NYSE: PFE) as a component of the Dow Jones Industrial Average nearly three years ago, the pharmaceutical company Amgen (NASDAQ: AMGN) is among the best dividend payers in its industry.  Let's dig into Amgen's fundamentals and valuation to get an answer to this question.  With around 24,000 employees in total, Amgen is a major drugmaker with a $124 billion market capitalization.""}, {""date"": ""20230517091300"", ""headline"": ""FTC Seeks to Block Amgen's Acquisition of Horizon Therapeutics: What's Next for Both Stocks?"", ""summary"": ""Deal or no deal? That's now the big question for investors concerning Amgen's (NASDAQ: AMGN) pending $28 billion acquisition of Horizon Therapeutics (NASDAQ: HZNP). The Federal Trade Commission (FTC) announced on Tuesday that it has filed a lawsuit to prevent this buyout from happening.""}, {""date"": ""20230517100730"", ""headline"": ""Analysis-Amgen's antitrust woes spur wider pharmaceutical deal fears"", ""summary"": ""Investors are scrambling to assess the fallout of a U.S. regulatory challenge against Amgen Inc's proposed $27.8 billion acquisition of Horizon Therapeutics Plc, with some fearing a spillover to other big deals in the drug sector.  While investors are accustomed to regulators under U.S. President Joe Biden citing potential harm to consumers in objecting to many large mergers, the U.S. Federal Trade Commission's (FTC) lawsuit filed on Tuesday surprised those who had brushed off the antitrust risk in Amgen's deal because of its limited business overlap with Horizon.""}, {""date"": ""20230517102400"", ""headline"": ""Applied Materials, Lowe`s added to Jefferies franchise picks list"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517102900"", ""headline"": ""Debt Ceiling Negotiations Turn a Corner. Why The Risk Isn\u2019t Over Yet."", ""summary"": ""Still no debt-ceiling deal as Biden shortens G-7 trip, UBS takes $35 billion gain from Credit Suisse takeover, Musk hints at two new vehicles and starts advertising campaign, and other news to start your day.""}, {""date"": ""20230517103500"", ""headline"": ""Amgen deal for Horizon likely to go through despite FTC objection: Guggenheim"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517105100"", ""headline"": ""Video: Dow Movers: AMGN, BA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517105200"", ""headline"": ""Amgen Becomes Oversold"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517122400"", ""headline"": ""Noteworthy Wednesday Option Activity: AMGN, LKQ, LYV"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230517123226"", ""headline"": ""Pfizer to raise $31 billion in debt offering to fund Seagen acquisition, SEC filing shows"", ""summary"": ""The debt offering by Pfizer to buy cancer drug maker Seagen comes as Apple, Merck and T-Mobile tap the U.S. bond market ahead of the debt ceiling standoff.\u00a0""}, {""date"": ""20230517123800"", ""headline"": ""Pfizer, Amgen, and 7 More Cheap Healthcare Stocks for Investors to Consider"", ""summary"": ""The stocks our screen found are cheap, relative to highfliers like Eli Lilly, and many are cheap for a reason.""}, {""date"": ""20230517133601"", ""headline"": ""Pfizer (PFE) to Raise $31B in Debt to Fund Seagen (SGEN) Deal"", ""summary"": ""Pfizer (PFE) offers bonds worth $31 billion to fund its pending acquisition of cancer drugmaker, Seagen (SGEN).""}, {""date"": ""20230517163600"", ""headline"": ""Amgen Inc. stock falls Wednesday, underperforms market"", ""summary"": ""Shares of Amgen Inc. sank 0.32% to $225.02 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500...""}, {""date"": ""20230517172630"", ""headline"": ""Amgen/FTC: deal bar ignores realities of pharma food chain"", ""summary"": ""No deal is fully inoculated against regulatory intervention.  In December, biopharmaceutical firm Amgen announced the acquisition of biotech star Horizon Therapeutics for $116.50 per share or $28bn in aggregate.  On Tuesday, the US Federal Trade Commission sued to block the deal.""}, {""date"": ""20230517181006"", ""headline"": ""FTC Challenges Amgen's (AMGN) $28B Acquisition of Horizon"", ""summary"": ""Per the FTC, Amgen's (AMGN) acquisition of Horizon (HZNP) would entrench the monopoly positions for the latter's medications for thyroid eye disease and chronic refractory gout.""}, {""date"": ""20230517190329"", ""headline"": ""M&A crackdown a \u2018disaster\u2019 for pharma sector, Pfizer executive warns"", ""summary"": ""A senior Pfizer executive has warned that a crackdown on mergers and acquisitions by antitrust regulators would be a \u201cdisaster\u201d for the system of innovation that underpins the pharmaceutical industry.  William Pao, Pfizer\u2019s chief development officer, said M&A is an important part of the funding ecosystem that supports the development of innovative therapies by scientists.  \u201cIf you can\u2019t get those M&A [deals] and then get those molecules distributed across the globe, it stifles innovation for sure,\u201d said Pao, who heads the Pfizer arm responsible for clinical development of drugs and ensuring a pipeline of new therapies.""}, {""date"": ""20230517202659"", ""headline"": ""Fed, labor market concerns showing 'some dents in the armor of the consumer': Strategist"", ""summary"": ""Hennion & Walsh CIO Kevin Mahn joins Yahoo Finance Live to discuss the state of the consumer amid retail earnings, Target Q1 earnings, Walmart earnings preview, Fed rate hikes, inflation, and the impact on consumer spending.""}, {""date"": ""20230517211813"", ""headline"": ""Dow Jones Today: Index Jumps on Debt Talk Hopes"", ""summary"": ""Home Depot and Boeing help lead the Dow more than 400 points higher, while Intel continued its losing streak""}, {""date"": ""20230517222949"", ""headline"": ""Unusual Put Option Trade in AMGEN (AMGN)  Worth $9,481.50K"", ""summary"": """"}, {""date"": ""20230517223552"", ""headline"": ""Unusual Put Option Trade in AMGEN (AMGN)  Worth $6,563.75K"", ""summary"": """"}, {""date"": ""20230518024200"", ""headline"": ""Top 5 1st Quarter Trades of INTERNATIONAL BIOTECHNOLOGY TRUST PLC"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518031300"", ""headline"": ""The FTC, Amgen, And Horizon: A New Hurdle For Biotech Deal Making Or Regulatory Overreach?"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518090900"", ""headline"": ""Supreme Court upholds Sanofi patent victory over Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518091200"", ""headline"": ""Supreme Court upholds Sanofi PCSK9 drug patent victory over Amgen"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518100000"", ""headline"": ""Anticompetitive Behavior At United Therapeutics, Regeneron, And The FTC"", ""summary"": ""Much of what the FTC attacks isn\u00e2\u0080\u0099t anticompetitive, it\u00e2\u0080\u0099s competitive. Click here to find out more on HZNP and LQDA.""}, {""date"": ""20230518101600"", ""headline"": ""Supreme Court rules against Amgen in Rapatha patent dispute with Sanofi/ Regeneron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518102200"", ""headline"": ""Supreme Court rules against Amgen in Repatha patent dispute with Sanofi/ Regeneron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518103004"", ""headline"": ""Horizon Therapeutics says Amgen deal could close earlier than planned if FTC fails to block it"", ""summary"": ""The new timeline is earlier than what Amgen, Horizon Therapeutics and Wall Street analysts were initially expecting after the FTC sued to block the deal. ""}, {""date"": ""20230518104900"", ""headline"": ""Regeneron `applauds` Supreme Court`s striking down Amgen`s patent claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518105900"", ""headline"": ""Sanofi `pleased` with Supreme Court`s ruling on Amgen`s asserted patent claims"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518123000"", ""headline"": ""Regeneron Says Supreme Court Ruling Ends Patent Dispute With Amgen"", ""summary"": ""By Denny Jacob Regeneron Pharmaceuticals on Thursday said a U.S. Supreme Court opinion affirms a lower court opinion that held Amgen's asserted U.S. PCSK9...""}, {""date"": ""20230518124800"", ""headline"": ""Amgen`s Horizon Deal Won`t Close before September"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230518124906"", ""headline"": ""U.S. court issues temporary restraining order on $27.8 bln Amgen-Horizon deal"", ""summary"": ""A U.S. district court has issued a temporary restraining order on Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics following a submission for it by the two companies and the U.S. Federal Trade Commission, Amgen said on Wednesday.""}, {""date"": ""20230518135552"", ""headline"": ""UPDATE 1-Amgen agrees not to seek quick close to Horizon acquisition"", ""summary"": ""Amgen Inc has agreed not to quickly close on its $27.8 billion acquisition of Horizon Therapeutics after the U.S. Federal Trade Commission (FTC) filed suit to block the deal.  A U.S. district court judge issued a temporary restraining order late on Wednesday after the two companies and the FTC reached an agreement that both sides said in a joint filing would permit a full briefing and \""less-compressed consideration\"" by the court of the FTC request.  Absent an agreement, Amgen could have sought to close the deal as early as Monday.""}, {""date"": ""20230518142002"", ""headline"": ""UPDATE 1-U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents"", ""summary"": ""The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive patents on its cholesterol-lowering drug Repatha over a legal challenge by French rival Sanofi SA.  The nine justices unanimously upheld a lower court's ruling that had invalidated Amgen's patents on the grounds that the Thousand Oaks, California-based drugmaker had failed to provide a roadmap for recreating the full scope of its claimed innovation.  Amgen has waged a years-long court battle to restore two of its patents on Repatha, a drug that can reduce the risk of heart attack and stroke in people with heart disease, stemming from a legal fight with Sanofi and its partner Regeneron Pharmaceuticals Inc.""}, {""date"": ""20230518155434"", ""headline"": ""Amgen agrees not to seek quick close to Horizon acquisition"", ""summary"": ""Amgen Inc has agreed not to quickly close on its $27.8 billion acquisition of Horizon Therapeutics after the U.S. Federal Trade Commission (FTC) filed suit to block the deal.""}, {""date"": ""20230518160559"", ""headline"": ""FTC effort to stop Amgen's Horizon takeover faces uphill fight"", ""summary"": ""The Federal Trade Commission (FTC) faces an uphill battle in its fight against Amgen Inc's $27.8 billion acquisition of Horizon Therapeutics with an untested argument before a Trump-appointed judge, three antitrust experts said.""}, {""date"": ""20230518163600"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 0.35% to $224.23 Thursday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230518164000"", ""headline"": ""Sanofi Wins Supreme Court Patent Dispute With Amgen"", ""summary"": ""The court said Amgen patents relating to its cholesterol drug Repatha shouldn\u2019t have been granted by the patent office, handing a victory to rival pharmaceutical firm Sanofi.""}, {""date"": ""20230518164728"", ""headline"": ""U.S. Supreme Court rules against Amgen bid to revive cholesterol drug patents"", ""summary"": ""The U.S. Supreme Court on Thursday ruled against Amgen Inc in its bid to revive patents on its cholesterol-lowering drug Repatha in a legal clash with French rival Sanofi SA.""}, {""date"": ""20230518180000"", ""headline"": ""5 High Yield Stocks With Steady Dividend Growth And An Attractive Valuation"", ""summary"": ""I consider companies that combine a relatively high Dividend Yield and Dividend Growth Rate to be particularly attractive for dividend income investors. Read more here.""}, {""date"": ""20230518180408"", ""headline"": ""Blocking the Horizon-Amgen deal will be worse for pharma than for biotech, says Mizuho's Jared Holz"", ""summary"": ""Jared Holz, Mizuho healthcare sector strategist, joins 'Fast Money' to discuss merger and acquisition crackdowns in the biotech space, government regulation in the space, and more.""}, {""date"": ""20230518185258"", ""headline"": ""Why Viking Therapeutics Stock Is Buckling Today"", ""summary"": ""Shares of the clinical-stage metabolic disorder specialist Viking Therapeutics (NASDAQ: VKTX) were down by 6.45% on moderate volume as of 1:42 p.m. ET Thursday afternoon.  Small- and mid-cap biotech stocks are under pressure today following the Federal Trade Commission's (FTC) decision to sue over the proposed merger between Amgen\u00a0and Horizon Therapeutics\u00a0earlier this week.  Before investors get too concerned, however, it's important to understand what's actually driving this takeover speculation.""}, {""date"": ""20230518233117"", ""headline"": ""Oppenheimer Reiterates AMGEN (AMGN) Outperform Recommendation"", ""summary"": """"}, {""date"": ""20230519003200"", ""headline"": ""GLOBAL BRIEFING: Japanese inflation hits 3.4%; new sanctions on Russia"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230519014300"", ""headline"": ""Amgen (NASDAQ:AMGN) Loses Patent Battle to Sanofi, Regeneron"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230519093500"", ""headline"": ""3 Safe Dividend Stocks to Beat Inflation"", ""summary"": ""Inflation rates may finally be cooling down from last year's unnerving levels.  Plenty of dividend-paying companies are dishing out -- and growing -- their dividend payments generously enough to outpace inflation's impact.  Here's a closer look at three such dividend stocks to consider adding to the income-paying portion of your portfolio.""}, {""date"": ""20230519111522"", ""headline"": ""5 Things to Know Before Markets Open"", ""summary"": ""President Biden said he was confident that negotiators would reach a deal on the debt ceiling and Fed Chair Jerome Powell is set to speak on monetary policy. Here\u2019s what investors need to know today.""}, {""date"": ""20230519163600"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.36% to $223.42 Friday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230519174240"", ""headline"": ""A global antitrust alliance battles Microsoft and Amgen"", ""summary"": ""As the EU approved Microsoft\u2019s $75bn bid to buy Activision Blizzard, the US Federal Trade Commission sued to block Amgen\u2019s $28.3bn deal to acquire Horizon Therapeutics and warned of \u201crampant consolidation\u201d in pharmaceuticals.  Margrethe Vestager, EU competition commissioner, is known as the nemesis of Big Tech but others are taking her place.  The Amgen suit epitomises the tough approach adopted by Lina Khan, chair of the FTC, and Khan has a new ally: Sarah Cardell, chief executive of the UK Competition and Markets Authority.""}, {""date"": ""20230519175600"", ""headline"": ""Washington Is Coming Down Hard on Deal Making. What It Means for Stocks."", ""summary"": ""FTC Chair Khan now seems less interested in ensuring competition than in blocking all linkups on principle. And that includes acquisitions that wouldn\u2019t have earned more than a passing look under previous regimes""}, {""date"": ""20230519215000"", ""headline"": ""Walmart, Tesla, Micron: Stocks That Defined the Week"", ""summary"": ""Retail giant  Walmart  posted stronger-than-expected profit and revenue and raised its full-year profit outlook, as the company\u2019s stores attract price-sensitive customers who have curtailed spending elsewhere.  Walmart said it continued to gain grocery market share, including among higher-income shoppers.  Walmart shares rose 1.3% Thursday.""}, {""date"": ""20230520110042"", ""headline"": ""We Think Amgen (NASDAQ:AMGN) Can Stay On Top Of Its Debt"", ""summary"": ""Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...""}, {""date"": ""20230521073258"", ""headline"": ""Viridian Therapeutics Has Promise"", ""summary"": ""Shares of Viridian Therapeutics are off some 40% since setting an all-time high in January following a positive readout on VRDN-001. Click for more on VRDN.""}, {""date"": ""20230521091933"", ""headline"": ""4 big deal reports: Amgen-Horizon merger on the ropes"", ""summary"": ""Here is your Pro Recap of 4 head-turning deal dispatches you may have missed this week: potential block of Horizon/Amgen transaction, merger deals at Magellan Midstream/Oneok and Urstadt Biddle/Regency Centers, and New Relic\u2019s potential $5B acquisition.  InvestingPro subscribers got this news before anyone else.  Horizon Therapeutics (NASDAQ:HZNP) shares plunged more than 14% on Tuesday after the report that the U.S. Federal Trade Commission (FTC) is expected to introduce a lawsuit to block the proposed $27.8 billion merger with Amgen (NASDAQ:AMGN).""}, {""date"": ""20230521110100"", ""headline"": ""Billions of dollars at stake as FDA shortcut allows half-proven drugs - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}]",{}
19,2023-05-21,219.89537048339844,2023-05-28,213.50775146484375,-0.029048447016018164,D3,"[{""date"": ""20230521073258"", ""headline"": ""Viridian Therapeutics Has Promise"", ""summary"": ""Shares of Viridian Therapeutics are off some 40% since setting an all-time high in January following a positive readout on VRDN-001. Click for more on VRDN.""}, {""date"": ""20230521091933"", ""headline"": ""4 big deal reports: Amgen-Horizon merger on the ropes"", ""summary"": ""Here is your Pro Recap of 4 head-turning deal dispatches you may have missed this week: potential block of Horizon/Amgen transaction, merger deals at Magellan Midstream/Oneok and Urstadt Biddle/Regency Centers, and New Relic\u2019s potential $5B acquisition.  InvestingPro subscribers got this news before anyone else.  Horizon Therapeutics (NASDAQ:HZNP) shares plunged more than 14% on Tuesday after the report that the U.S. Federal Trade Commission (FTC) is expected to introduce a lawsuit to block the proposed $27.8 billion merger with Amgen (NASDAQ:AMGN).""}, {""date"": ""20230521110100"", ""headline"": ""Billions of dollars at stake as FDA shortcut allows half-proven drugs - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523011800"", ""headline"": ""Check Out What Whales Are Doing With AMGN"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523013100"", ""headline"": ""Amgen, J&J settle lawsuit over Stelara biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523033900"", ""headline"": ""Amgen Takes Over #60 Spot From Union Pacific"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523062615"", ""headline"": ""SGEN, ACAD & BMEA Drove Baker Brothers Advisors' Q1 Returns as ASND and HZNP Were Culled"", ""summary"": """"}, {""date"": ""20230523114600"", ""headline"": ""Amgen, J&J settle patent lawsuit over Stelara biosimilar, Reuters reports"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523122000"", ""headline"": ""Bayer, Amgen looked at Iveric before agreeing to Astellas sale - report"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523124100"", ""headline"": ""10 Health Care Stocks Whale Activity In Today's Session"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230523142739"", ""headline"": ""Amgen settles J&J patent lawsuit over drug similar to blockbuster Stelara"", ""summary"": ""Johnson & Johnson's Janssen Biotech Inc has settled its lawsuit against Amgen Inc over Amgen's proposed similar version of J&J's top-selling drug Stelara, according to a filing Monday in Delaware federal court.""}, {""date"": ""20230523150127"", ""headline"": ""UPDATE 2-Amgen settles patent lawsuit over biosimilar of J&J's  big-selling Stelara"", ""summary"": ""Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions,  according to a filing in Delaware federal court.  Amgen said in a statement on Tuesday that the settlement terms are confidential, but it will allow the company to sell its biosimilar of Stelara \""no later than January 1st, 2025.\""""}, {""date"": ""20230523153543"", ""headline"": ""Amgen settles patent lawsuit over biosimilar of J&J's  big-selling Stelara"", ""summary"": ""Johnson & Johnson has settled its lawsuit over Amgen Inc's proposed biosimilar version of J&J's top-selling treatment Stelara for psoriasis and other autoimmune conditions, according to a filing in Delaware federal court.""}, {""date"": ""20230523154506"", ""headline"": ""UPDATE 1-US judge hearing fight over Amgen deal for Horizon eyes September trial"", ""summary"": ""The judge who will decide if Amgen can go forward with its $27.8 billion purchase of Horizon Therapeutics on Tuesday said he was considering an evidentiary hearing on the matter in September.  Judge John Kness said he would likely take about four weeks after the hearing ends to make a ruling.  The case is being heard in federal court in Chicago.""}, {""date"": ""20230523155310"", ""headline"": ""US judge hearing fight over Amgen deal for Horizon eyes September trial"", ""summary"": ""The judge who will decide if Amgen can go forward with its $27.8 billion purchase of Horizon Therapeutics on Tuesday said he was considering an evidentiary hearing on the matter in September.""}, {""date"": ""20230523163600"", ""headline"": ""Amgen Inc. stock outperforms market on strong trading day"", ""summary"": ""Shares of Amgen Inc. inched 0.20% higher to $224.44 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500...""}, {""date"": ""20230524022100"", ""headline"": ""Noteworthy Wednesday Option Activity: AMGN, GPRE, RETA"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230524091500"", ""headline"": ""FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?"", ""summary"": ""The Federal Trade Commission (FTC) has been taking a much more adversarial approach to mergers and acquisitions lately.  For instance, it recently said it plans to block the pending deal between pharmaceutical companies Horizon Therapeutics (NASDAQ: HZNP) and Amgen (NASDAQ: AMGN).  Does the FTC's recent tough stance on big deals increase the chances that Pfizer's (NYSE: PFE) acquisition of Seagen (NASDAQ: SGEN) will also run into problems?""}, {""date"": ""20230524110000"", ""headline"": ""Elizabeth Warren and the FTC Are the Least of Amgen\u2019s Problems"", ""summary"": ""The Internal Revenue Service has gone after the biotech for billions of dollars in back taxes.  Lina Khan\u2019s Federal Trade Commission is seeking to block its $27.8 billion acquisition of  Horizon Therapeutics  (a move some insiders think was at least partly prompted by a blistering letter from Sen. Elizabeth Warren).""}, {""date"": ""20230524133342"", ""headline"": ""14 Best Healthcare Dividend Stocks to Buy"", ""summary"": ""In this article, we will take a look at 14 best healthcare dividend stocks to buy. You can skip our detailed analysis of the healthcare sector and dividend stocks, and go directly to read 5 Best Healthcare Dividend Stocks to Buy. The healthcare sector in the US encompasses a wide range of providers, facilities, and [\u2026]""}, {""date"": ""20230524163600"", ""headline"": ""Amgen Inc. stock underperforms Wednesday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slid 1.39% to $221.32 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230525020400"", ""headline"": ""Dow's 90-point fall led by losses for shares of Intel, Walgreens Boots"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230525040700"", ""headline"": ""Novartis' Sandoz gets EMA review for biosimilar to Amgen's Prolia, Xgeva"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230525080352"", ""headline"": ""14 Best Biotech Stocks To Buy According To Hedge Funds"", ""summary"": ""In this piece, we will take a look at 14 best biotechnology stocks to buy according to hedge funds. For more stocks, head on over to 5 Best Biotech Stocks To Buy According To Hedge Funds. Biotechnology is one of the hottest sectors these days. A handful of industries, such as space exploration, artificial intelligence, [\u2026]""}, {""date"": ""20230525105200"", ""headline"": ""Dow drops 175 points on losses in Intel, Walgreens Boots shares"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230525120700"", ""headline"": ""Intel, Verizon share losses lead Dow's nearly 100-point drop"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230525161909"", ""headline"": ""3 Dogs of the Dow for High-Yield Investors"", ""summary"": ""The \u201cDogs of the Dow\u201d strategy consists of investing in the 10 highest-yielding stocks in the Dow Jones Industrial Average. Purchasing the Dogs of the Dow creates higher dividend income by focusing on high-yielding stocks. This is a simple strategy for value investors looking to purchase high-yield dividend stocks with reasonable valuations. The following three stocks are part of the 10 Dogs of the Dow. They have high dividend yields and strong business models and should maintain their dividends""}, {""date"": ""20230525163600"", ""headline"": ""Amgen Inc. stock underperforms Thursday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. slipped 1.74% to $217.46 Thursday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230526093000"", ""headline"": ""A Challenger to J&J's Top Blockbuster Is on the Way. Here's What You Need to Know."", ""summary"": ""When you think of Johnson & Johnson (NYSE: JNJ), you may think of shampoo and Band-Aids.  In fact, J&J is in the process of spinning off that business into an entity called Kenvue.  What is J&J's top revenue driver?""}, {""date"": ""20230526094800"", ""headline"": ""Nvidia Pops 25% on Super Guidance"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230526123400"", ""headline"": ""Is the Options Market Predicting a Spike in Amgen (AMGN) Stock?"", ""summary"": ""Investors need to pay close attention to Amgen (AMGN) stock based on the movements in the options market lately.""}, {""date"": ""20230526163600"", ""headline"": ""Amgen Inc. stock underperforms Friday when compared to competitors"", ""summary"": ""Shares of Amgen Inc. dropped 0.24% to $216.93 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230526200000"", ""headline"": ""AMGEN TO PRESENT AT THE TD COWEN 4TH ANNUAL ONCOLOGY INNOVATION SUMMIT"", ""summary"": ""Amgen (NASDAQ: AMGN) will present at the TD Cowen 4th Annual Oncology Innovation Summit at 11:00 a.m. ET on Wednesday, May 31, 2023. David M. Reese, M.D., executive vice president of Research and Development at Amgen will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.""}]",{}
20,2023-05-28,213.50775146484375,2023-06-04,215.08250427246094,0.007375623586558522,U1,"[{""date"": ""20230529050200"", ""headline"": ""Top-Ranked Dividend Stocks: A Smarter Way To Boost Your Retirement Income"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230529053615"", ""headline"": ""Amgen: Appeal Becomes Visible Despite Uncertainty On The 'Horizon'"", ""summary"": ""Amgen's stock has seen a further pullback since it announced acquisition of Horizon Therapeutics in December. Check out my thoughts on AMGN stock.""}, {""date"": ""20230529120020"", ""headline"": ""Amgen's (NASDAQ:AMGN) underlying earnings growth outpaced the notable return generated for shareholders over the past five years"", ""summary"": ""When you buy and hold a stock for the long term, you definitely want it to provide a positive return. Better yet, you'd...""}, {""date"": ""20230530033200"", ""headline"": ""Quant Ratings Updated on 107 Stocks"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230530090500"", ""headline"": ""Amgen: Now At A Record High Yield"", ""summary"": ""Amgen (AMGN) stock is trading near its 52-week low, presenting a potential opportunity for long-term investors.""}, {""date"": ""20230530100000"", ""headline"": ""LABU: 2 Requirements For Making Money In This Leveraged Biotech Fund"", ""summary"": ""LABU is 3X leveraged fund that has disappointed the biotech bulls. It can work for medium term returns if two requirements are met. See more on this ETF here.""}, {""date"": ""20230530100100"", ""headline"": ""Viridian an outperform at RBC on thyroid eye disease candidate"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230530103049"", ""headline"": ""Top Merger Stocks Held By Fund Managers, Mid-Q2 2023"", ""summary"": ""Merger arbitrage in mid-2023 faces regulatory hurdles, with agencies attempting to block deals across industries. Read more here.""}, {""date"": ""20230530150246"", ""headline"": ""Iveric bio, Still A 5+% Opportunity"", ""summary"": ""Iveric bio, focused on developing treatments for retinal diseases, has announced its acquisition by Astellas Pharma Inc. Find out our thoughts on ISEE stock.""}, {""date"": ""20230530163600"", ""headline"": ""Amgen Inc. stock rises Tuesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.74% higher to $218.53 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500...""}, {""date"": ""20230530220000"", ""headline"": ""AMGEN PRESENTS NEW RESEARCH ON OTEZLA\u00ae (APREMILAST) IN PSORIATIC ARTHRITIS AT EULAR 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced new research examining the use of Otezla\u00ae (apremilast) in psoriatic arthritis, including the Phase 4 MOSAIC study and an exploratory analysis of cardiometabolic risk factors, which are commonly elevated in patients with psoriatic disease. The findings will be presented at the 2023 European Congress of Rheumatology (EULAR), taking place May 31-June 3 in Milan, Italy.""}, {""date"": ""20230531142024"", ""headline"": ""Amgen Inc. (AMGN) 4th Annual Oncology Innovation Summit: Insights for ASCO & EHA (Transcript)"", ""summary"": ""Amgen Inc. (NASDAQ:NASDAQ:AMGN) 4th Annual Oncology Innovation Summit: Insights for ASCO & EHA May 31, 2023 11:00 AM ETCompany ParticipantsDavid Reese - Executive Vice President of...""}, {""date"": ""20230531163600"", ""headline"": ""Amgen Inc. stock rises Wednesday, outperforms market"", ""summary"": ""Shares of Amgen Inc. inched 0.97% higher to $220.65 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500...""}, {""date"": ""20230531202915"", ""headline"": ""2 Large Cap Biotech Stocks To Watch Right Now"", ""summary"": ""Large-cap biotech stocks to check out in the stock market today.""}, {""date"": ""20230601023900"", ""headline"": ""Amgen (AMGN) Shares Cross 4% Yield Mark"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601051601"", ""headline"": ""Tracking Baker Brothers Portfolio - Q1 2023 Update"", ""summary"": ""Baker Brothers' 13F portfolio value increased from $16.65B to $18.38B. Click here to read the portfolio's full Q1 2023 update.""}, {""date"": ""20230601082500"", ""headline"": ""Mark Cuban online pharmacy to offer AbbVie Humira biosimilar"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601094500"", ""headline"": ""Salesforce, Amgen share losses contribute to Dow's nearly 150-point fall"", ""summary"": ""Shares of Salesforce and Amgen are trading lower Thursday morning, dragging the Dow Jones Industrial Average into negative territory. Shares of Salesforce...""}, {""date"": ""20230601101300"", ""headline"": ""Wells says Coherus' Humira biosimilar pricing 'actually good news' for AbbVie"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601103900"", ""headline"": ""AMGN July 14th Options Begin Trading"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601111700"", ""headline"": ""House Committee starts probe into FTC Chair Lina Khan"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601123400"", ""headline"": ""Notable Thursday Option Activity: AMGN, ABBV, RCL"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230601130000"", ""headline"": ""AMGEN PRESENTS NEW SCIENTIFIC AND CLINICAL RESEARCH ACROSS ITS DIVERSE ONCOLOGY PORTFOLIO AND PIPELINE AT ASCO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new scientific and clinical research across its diverse oncology portfolio and pipeline at the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place from June 2-6 in Chicago. More than 25 abstracts from Amgen-sponsored and collaborative studies, including three oral presentations and two poster discussions, will feature data in hard-to-treat tumor types, including non-small cell lung cancer (NSCLC), colorectal cancer (CR""}, {""date"": ""20230601160000"", ""headline"": ""Is Amgen a Good Dividend Stock?"", ""summary"": ""Biotech pioneer Amgen (NASDAQ: AMGN) has several key elements of a good dividend stock.  Amgen is also a component of the Dow Jones Industrial Average and Nasdaq-100 index, making its shares highly liquid.  Amgen is moving into a highly uncertain period, characterized by high levels of competition from biosimilars (generic biologics) for many of its aging blockbusters, pushback from the Federal Trade Commission over its proposed takeover of Horizon Therapeutics (NASDAQ: HZNP), and serious question marks surrounding the rationale of this $28 billion buyout.""}, {""date"": ""20230601163700"", ""headline"": ""Amgen Inc. stock falls Thursday, underperforms market"", ""summary"": ""Shares of Amgen Inc. slid 2.89% to $214.27 Thursday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index...""}, {""date"": ""20230601165020"", ""headline"": ""Why AbbVie and Amgen Are Moving Lower Today"", ""summary"": ""Shares of the immunology juggernaut AbbVie (NYSE: ABBV) were down by 4% on sky-high volume as of 11 a.m. ET Thursday.  The big loss came after Coherus Biosciences\u00a0announced a partnership with billionaire Mark Cuban's pharmaceuticals start-up -- known as the Mark Cuban Cost Plus Drug Company -- to sell a biosimilar (a generic biologic) version of AbbVie's flagship anti-inflammatory medication, Humira, at an 85% discount.  Coherus' biosimilar will be branded as Yusimry.""}, {""date"": ""20230601205529"", ""headline"": ""Dow Jones Today: Debt Vote Drives Index Higher"", ""summary"": ""The Dow Jones Industrial Average moved higher by more than 0.5%, or 153 points, as investors celebrated the House of Representatives passage of the debt-ceiling bill, which now goes to the Senate.""}, {""date"": ""20230602110026"", ""headline"": ""Possible Bearish Signals With Amgen Insiders Disposing Stock \\"", ""summary"": ""Over the past year, many Amgen Inc. ( NASDAQ:AMGN ) insiders sold a significant stake in the company which may have...""}, {""date"": ""20230602114329"", ""headline"": ""High Yield Stock Watchlist: June 2023"", ""summary"": ""There are 20 stocks on my high yield watchlist for June 2023. The majority of the stocks on my watchlist are undervalued based on dividend yield theory. Read more here.""}, {""date"": ""20230602115532"", ""headline"": ""3 Undervalued Biotech Stocks to Buy Before They Blast Off"", ""summary"": ""When investors hear the words \u201cundervalued biotech stocks to buy,\u201d they frequently think of companies in the clinical trial stage. That\u2019s understandable. If you can buy a company\u2019s stock before it releases a game-changing drug or therapeutic into the market, you can make a fortune. That line of thinking was displayed in 2020 when many biotech companies raced to produce a Covid-19 vaccine. But every investor also knows that many of those moonshots never pan out. That\u2019s not the kind of uncertainty""}, {""date"": ""20230602163900"", ""headline"": ""Amgen Inc. stock outperforms competitors on strong trading day"", ""summary"": ""Shares of Amgen Inc. advanced 1.77% to $218.07 Friday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500...""}, {""date"": ""20230602171733"", ""headline"": ""The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree"", ""summary"": ""Big Pharma has a problem, and buying up biotech companies helps solve it. But the FTC has its own ideas about industry mergers. Here's where things stand.""}, {""date"": ""20230603074100"", ""headline"": ""Analysts Conflicted on These Healthcare Names: Amgen (AMGN) and Natera (NTRA)"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230603090000"", ""headline"": ""How To Build Wealth: Buy Low And Sell High Consistently"", ""summary"": ""The strategy discussed is about buying or selling small quantities of shares when certain thresholds are met. Click here to read more about that strategy.""}, {""date"": ""20230604022807"", ""headline"": ""Dividend Champion, Contender, And Challenger Highlights: Week Of June 4"", ""summary"": ""A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Click here to read the complete list.""}, {""date"": ""20230604074800"", ""headline"": ""Amgen presents new LUMAKRAS CodeBreaK 200 CNS data at ASCO"", ""summary"": ""Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.""}, {""date"": ""20230604120000"", ""headline"": ""AMGEN PRESENTS NEW LUMAKRAS\u00ae (SOTORASIB) CODEBREAK 200 CNS DATA AT ASCO 2023"", ""summary"": ""Amgen (NASDAQ:AMGN) today announced the presentation of new data from the CodeBreaK clinical trial program, the most comprehensive global development program in patients with KRAS G12C-mutated cancers, at the American Society of Clinical Oncology (ASCO) Annual Meeting taking place June 2-6 in Chicago. The research presented reinforces the efficacy of LUMAKRAS\u00ae/LUMYKRAS\u00ae (sotorasib) in advanced non-small cell lung cancer (NSCLC) and metastatic colorectal cancer (mCRC). Additionally, data from SCA""}]",{}
